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Abstract 
Mycobacterium tuberculosis, the causative agent of tuberculosis (TB), is responsible for the 
largest number of deaths due to a single bacterial pathogen. The persistence of TB in society 
is exacerbated by multiple factors, including the emergence of drug resistant forms of M. 
tuberculosis such as multi-, extensively- and totally-drug strains, which have fuelled a race 
for the discovery of new drugs with novel modes of action. However, the metabolic 
flexibility inherent in the tubercle bacillus has made the identification of vulnerable drug 
targets difficult. The peptidoglycan (PG) layer in the mycobacterial cell wall plays an 
essential role in bacterial growth, survival and antibiotic resistance but has not been 
exploited for TB drug development. In this study, we characterized the physiological 
function of mycobacterial DD-Carboxypeptidases (DD-CPases), a subgroup of Low 
Molecular Weight penicillin binding proteins (LMW PBPs), implicated in modulating the 
amount of PG cross-linking, thereby regulating the growth and remodelling of the PG 
polymer. Given that DD-CPases have not been characterized in actinobacteria, this study 
comprised the identification of M. smegmatis DD-CPases interacting partners, using the 
mycobacterial Protein Fragment complementation assay (mPFC), and interrogation of the 
functionality of the M. tuberculosis DD-CPase homologues through heterologous 
complementation in M. smegmatis. The Two DD-CPases, encoded by the MSMEG_2433 and 
MSMEG_6113 loci in M. smegmatis, were chosen for the identification of putative 
interacting partners. Screening of a genomic library using the mPFC assay identified 30 and 
10 possible interacting partners for MSMEG_2433 and MSMEG_6113 respectively. 
Notably, some of these interacting partners included key regulators of cell elongation 
(PonA1) or division (PbpA and PbpB) and point to an important function for DD-CPases 
during mycobacterial growth. To further assess if genetic multiplicity for DD-CPases in M. 
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tuberculosis is reflective of an underlying functional redundancy between these enzymes, the 
M. tuberculosis DD-CPase homologues (Rv2911, Rv3627c and Rv3330) were assessed for 
functionality through ectopic expression in M. smegmatis. The resulting heterologous M. 
smegmatis strains displayed altered colony morphology, with smooth colonies that displayed 
a mucoid surface and cording defects. Ectopic expression of the M. tuberculosis DD-CPases 
in M. smegmatis also resulted in aberrant biofilm formation and affected bacterial sliding on 
semi-solid agar, indicative of an alteration in the three-dimensional packing of cells in a 
community or changes in membrane properties. Over-expression of Rv2911 and Rv3627c 
resulted in reduced bacterial cell length accompanied by division defects. Transmission 
electron microscopy revealed that the M. tuberculosis DD-CPase homologues are involved in 
maintaining normal bacterial cell wall architecture. Over-expression of these homologues in 
native wild type M. tuberculosis H37RvS revealed a role for Rv3627c in regulating bacterial 
colony morphology. Cellular localization studies with rseGFP C-terminally tagged 
derivatives of these proteins revealed that they localize at the poles, mid-cell or and quarter-
cell positions, further suggestive of a role in temporal and spatial co-ordination of cell 
growth and division. Collectively, the data point to important, possibly redundant roles for 
the multiple DD-CPases-encoding genes in M. tuberculosis and highlights these proteins as 
possible new drug targets for TB.  
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1.1. Introduction  
1.1.1. Background  
M. tuberculosis, a slow growing bacterium and the causative agent of tuberculosis (TB), is a 
significant cause of morbidity and mortality globally. TB causes approximately 1.3 million 
deaths annually, with 8-10 million new infections (Corbett et al., 2003). The World Health 
Organization (WHO) estimated that in 2014, TB claimed 1.5 million lives, wherein 1.1 and 
0.4 million were reported to occur in HIV-negative and HIV-positive individuals, 
respectively (WHO, 2015). A similar trend was documented in 2013, with an increasing 
number of deaths reported for women and children. Furthermore, the WHO reported for the 
first time that TB associated deaths in 2014 surpassed that of HIV associated deaths (WHO, 
2014). TB infection and associated active disease is prevalent in developing countries and 
further exacerbated by increased HIV infection rates. The high burden endemic countries 
with reportedly high numbers of TB infection in 2014 according to the WHO are as follows; 
India, Indonesia, China, Nigeria, Pakistan and South Africa, figure 1.1.1. In these countries, 
various socio-economic factors such as urbanization, over-crowding, poor nutrition and 
stigma facilitate sustained transmission of TB and failure to address these will ensure that 
human society continues to face a massive on-going and future burden of TB disease.  
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Figure 1.1.1. A global representation of TB incidence in 2014 as reported by the World 
Health Organization. The high burden regions include Asia and Sub-Saharan africa. (WHO, 
2015) 
 
1.2. Tuberculosis chemotherapy  
1.2.1. Current drug regimen 
Combinatorial chemotherapy involving numerous first line drugs is used for treatment of 
drug susceptible TB. These antibiotics comprise rifampicin, isoniazid, pyrazinamide and 
ethambutol for first two months of treatment, followed by chronic treatment for four months 
with rifampicin and isoniazid. This approach, to a greater extent, has been used to effectively 
manage TB in many countries (Duncan, 2013; Zumla et al., 2013). The above mentioned 
treatment regimen forms the basis of the WHO recommended directly observed therapy 
short course strategy, adopted in the early 1990’s, where a patient is required to take 
medication in the presence of a health care provider, ensuring compliance (Raviglione and 
Pio, 2002; Dye et al., 1998). These efforts, together with administration of the Bacille 
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Calmette-Guérin vaccine (BCG) for prevention of disseminated TB in early childhood, 
(Colditz et al., 1994; Anderson et al., 2005) have significantly reduced rampant spread of TB 
globally. However, despite this, TB continues to claim millions of lives, a situation that 
requires urgent and effective interventions. 
Much of the success of M. tuberculosis as a human pathogen is related to the amazing 
responsiveness of the tubercle bacillus to stress conditions, which is illustrated by: (I) the 
ability of the bacterium to escape host defence mechanisms such as the production of 
reactive oxygen/nitrogen species and the maturation of the phagosomes (Tufariello et al., 
2003) (II) the inherent ability to spontaneously evolve drug resistance through chromosomal 
mutation of essential drug targets (Nachamkin et al., 1997; Telenti, et al., 1993; Heep et al., 
2001) (III) the propensity to adopt alternative growth states (active growth vs. non-
replicating persistence vs. the lack of culturability), an effect which is dependent on the  host 
immune status (Zhang et al., 2004; Parrish et al., 1998; Ahmad et al., 2010) (IV) the 
occupation of different niches during infection, with different physiological conditions 
which affect the biochemical properties and efficacy of antibiotics (Iseman and Madsen, 
1991; Elliott,  et al., 1995) (V) the presence of a complex hydrophobic cell envelope, which 
does not allow for easy diffusion of small molecules such as antibiotics and (VI) the 
presence of numerous drug efflux systems that pump out antibiotics, thereby reducing their 
intracellular concentration (Domenech et al., 2005; Rossi et al., 2006; Louw et al., 2009).  
These and other factors have essentially fuelled the current TB pandemic as they create a 
clinical spectrum of disease that is difficult to manage through national control programs in 
endemic countries. Drug resistant TB [multi-(MDR), extensively (XDR) and totally (TDR)- 
drug resistant] are a particular challenge and require extended periods of treatment with a 
combination of both first and second line drugs (Centers for Disease Control and Prevention, 
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2006; Suárez et al., 2002; Gandhi et al., 2006). The second line drugs in this case include, 
aminoglycosides (kanamycin, capreomycin and amikacin), fluoroquinolones (moxifloxacin, 
gatifloxacin) (Ma et al. 2010; Stass et al. 1998) and bedaquiline (Diacon et al. 2013; 
Mahajan, 2013), which are extremely toxic and cause severe side effects. However, another 
major obstacle to the design of effective anti-TB drugs is drug-drug interaction, especially in 
immune compromised HIV-infected individuals taking both anti-TB drugs together with 
antiretroviral treatment (ARV).  
1.2.2. Drug-drug interactions.  
Currently, the emergence of drug resistant forms of M. tuberculosis have necessitated the 
design of effective new anti-TB-drugs, but success will only be achieved through integration 
of both old and new drug regimens together with antiretroviral therapy or any other form 
therapy, in a combination that will allow for each drug to effectively act on its target (Koul et 
al., 2011). Additionally, negative interactions between TB drugs and other drugs intended to 
treat a different condition (diabetes, cholesterol, hypertension etc.), are not the only forms of 
interaction that can occur as anti-TB drugs can cross react with each other (Bhutani et al., 
2005). This limits the combinations of drugs that can be prescribed for a patient with co-
morbid TB diseases.  
Rifampicin, an essential anti-TB drug, that together with isoniazid, allows for effective early 
bactericidal activity and increased cure rates (Fox et al., 1999) reduces the serum 
concentration of protease inhibitors in HIV-infected individuals on ART (Ribera et al., 2001; 
Haas et al., 2009). Rifampicin also induces expression of the hepatic cytochrome P450 
enzyme systems and P-glycoproteins, which increase the metabolism of efavirenzi and 
nevarapine (Ribera et al., 2001) and a number of other antiretroviral agents (Haas et al., 
2009; Requena et al., 2005), thereby reducing serum concentrations and ultimate 
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effectiveness of ART. Alternatively, rifabutin provides a tractable replacement for 
rifampicin, which also induces the cytochrome P-450 enzyme system and P-glycoproteins 
but at lower levels compared to rifampaicin (Gonzalez-Montaner et al., 1994; Carto 3
rd
 et al., 
1998). However, a safe dosage of rifabutin, when co-administered with antiretroviral therapy 
was not determined (Khachiet al., 2009) until recently (Lan et al., 2014), thus providing a 
new therapeutic option for TB-HIV infected individuals.   
An additional impediment with treatment of HIV-TB co-infection is the general toxicity of 
both regimens, especially in the case of drug resistance. Therefore, in the case of TB-HIV 
co-infection, patients will present multiple or overlapping side effects and this will 
potentially result in the disruption/discontinuation of optimized therapy to minimize the 
toxicity of the drugs to the patient (Dean et al., 2002). As such, new drugs with novel modes 
of action that would be active on both drug susceptible and drug resistant forms of TB, that 
exhibit no cross interactions with ART, now present as an urgent necessity.   
The capacity of an organism to establish disease in a host, to persist and disseminate as in 
the case of TB infection, requires two fundamental processes; growth and division, both of 
which have to occur under substantive immune assault and drug treatment. The study of 
mycobacterial cell division and elongation is still in its infancy and further in-roads are 
required to develop a holistic understanding of these essential processes. A key feature of 
successful bacterial cell division is the ability to rapidly remodel the multiple layers of the 
cell envelope to allow for insertion of new cell wall units and degradation of the septum to 
facilitate daughter cell separation. This MSc focuses on the remodelling of the peptidoglycan 
(PG) layer in the mycobacterial cell wall, with the aim of uncovering new drug targets that 
are essential for remodelling this polymer during growth. 
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1.3. The mycobacterial cell envelope  
The mycobacterial cell envelope, like in any bacterial species, is central to growth and 
survival as it provides a barrier to external stress (Mikušova et al., 2000).  It consists of three 
distinct layers including the plasma membrane, the envelope core, and membrane bound 
lipids or extractable proteins that form part of the capsule-like layer (Alteens et al., 2008; 
Daffe and Etienne, 1999), figure 1.1.2.  
   
Plasma 
membrane  
Peptidoglycan 
Arabinogalactan
Mycolic Acids 
Capsule layer 
Core structure 
 
Figure 1.1.2. A diagrammatic representation of the mycobacterial cell wall. The image 
shows the three distinct layers of the mycobacterial: cell wall consisting of the capsule layer, 
the core structure and the plasma membrane. The core structure encompasses the mycolic 
acids, arabinogalactan and the peptidoglycan layer.   
 
The unique composition of these layers, detailed further below, has resulted in variable gram 
straining of mycobacteria, making it difficult to place these organisms under conventional 
classifications such as gram positive or gram negative (Smithwìck, 1976; Miller, 1972) 
The outer layer of the mycobacterial cell wall consists of various lipids, proteins and 
glycoprotein, (Daffe and Etienne, 1999), figure 1.1.2. The sugar components are 
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predominantly arabinomannan, α-glucan and mannan (Sani et al., 2010; Deffe and Etienne, 
2010). The surface exposed lipids include; lipopolysaccharides (Drapper et al., 1973), a 
variety of structurally related phenolic glycolipids (Boddingius et al., 1989) and 
Phthiocerol dimycocerosates (Hunter et al., 1983). The Phthiocerol dimycocerosates and 
lipopolysaccharides are major virulence factors, modifying the host immune response at the 
initial host-pathogen encounter (Astarie-Dequeker et al., 2009; Tobian et al., 2003; Moreno 
et al., 1988). The protein component of the outer layer consists largely of various ESX 
secretion protein complexes (Sani et al., 2010), malate synthase, the MtrA proteins (Marques 
et al., 1998) and β-lactam degrading proteins such as the β-lactamase BlaS (Poset et al., 
2006).  
The core structure consists of 3 distinct layers; mycolic acids (MAs), arabinogalactan (AG) 
and the PG layer. The MAs are the defining feature of the mycobacterial cell envelope 
(Daffe and Drapper, 1997) and represent a unique feature to actinomycetes. MAs are β-
hydroxyl fatty acids consisting of a long alkyl chain. (Asselineau et al., 1950). Mycobacterial 
species synthesize three different types of MAs; the α-, methoxy-, and keto-mycolic forms, 
and the α- form is the most abundant of the three (Qureshi et al., 1978; Watanabe et al., 
2001). These groups of fatty acids are ester linked to the galactofuran unit of AG (Liu et al. 
1996). They are hypothesized to contribute considerably to the hydrophobicity of the cell 
envelope, thereby determining the fluidity and permeability of the cell (Liu et al., 1996). The 
reduced general permeability of mycobacteria is the result of tightly packed MAs, which 
form a pseudo outer membrane that can be seen on electron micrographs (Sani et al., 2010) 
and contributes to increased drug tolerance, which eventually results in resistance, despite 
the presence of porins that facilitate diffusion of substances across the cell wall into the 
cytosol (Kartmann et al., 1999).  
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MAs are crucial in maintaining other cellular processes such as bacterial cording, biofilm 
formation and the associated drug tolerance of biofilm-derived bacteria (Ojah et al., 2008). 
In M. tuberculosis, MAs are modified by cyclopropanation and this type of modification is 
proposed to increase tolerance to oxidative damage (Yuan et al., 1995). The oxygenated 
forms of MAs are essential for virulence of M. tuberculosis in the murine model of TB 
infection (Dubnau et al., 200). The first line drug, isoniazid, targets biosynthesis of MAs 
(Takayama et al., 1972; Takayama et al., 1975, Winder et al., 1970), signifying the 
importance of this unique mycobacterial structure in growth, survival and disease 
progression in M. tuberculosis.  
The second layer of the core structure, AG, consists of two distinct units, arabinan and 
galactose (Daffe et al., 1990). The galactose component forms a polymer of 30 galactose 
residues and the arabinan component forms branches by attaching at position 5 of the 
galactose residues (Daffe et al., 1990; McNeil et al., 1990). This structure is sandwiched 
between the MA and PG layer, and acts as a point of attachment for these two polymers. The 
PG is linked to AG by a linker unit (-α-l-Rhap-(133)-d-GlcNAc-P-) (McNeil et al., 1990; 
Mikušova et al., 2000; Bhamidi et al., 2011). The three distinct MAs are esterified to the AG 
polymer (Liu et al. 1996). Ethambutol, another first line drug for TB treatment, targets 
polymerization of the arabinan units (through inhibition of the arabinosyl transferases) and 
mutations in the embB operon results in resistance to ethambutol (Belanger et al., 1996; 
Alcaide et al., 1997; Telenti et al., 1997).  
The third layer in the core structure of the mycobacterial cell envelope is the PG layer. This 
layer is unique to bacterial cells (Severin and Tomasz, 1996). In bacterial species, this 
structure fulfills a number of processes such as: (I) the maintenance of normal and uniform 
bacterial cell shape (Scheurwater and Burrows, 2011) (II) the prevention of cell lysis under 
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stress conditions such as increased internal cytoplasmic turgor/osmotic pressure (Royet et 
al,. 2007; Prigozhin et al. 2013) (III) it presents as a key component in the synthesis of the 
septum for bacterial growth and division (Begg and Donachie, 1985; Typas et al., 2012) (IV) 
involvement in inter- and intra-species cell signalling and signal transduction (Dworkin, 
2014; Wang et al., 2003) (V) it also plays role in  immune modulation (Boneca et al., 2007; 
Davis et al., 2011).  
As mentioned above, biosynthesis of MAs and the AG components of the mycobacterial cell 
wall are targeted with frontline anti-TB drugs, isoniazid and ethambutol. This suggests that 
the PG layer, by virtue of its role in bacterial growth and physiology, is a promising 
candidate for the design of effective and target based anti-TB drugs. The next section will 
focus on the biosynthesis and remodelling of this polymer in bacteria.  
1.4. Peptidoglycan biosynthesis 
1.4.1. Cytoplasmic steps in PG biosynthesis 
The biosynthesis of the PG layer is mediated by a variety of cytoplasmic and periplasmic 
enzymes. The cytoplasmic enzymes synthesize PG units, which are translocated across the 
membrane for incorporation into the existing PG polymer to facilitate cell growth and 
division, figure 1.1.3. The first committed to PG synthesis involves the conversion of NAG 
(N-acetylglucosamine) sugar residues into UDP-NAG (uridinediphosphate N-
acetylglucosamine) and this is hypothesized to be catalyzed by FlmU in mycobacteria (Hett 
and Rubin, 2008). This is followed by the addition of the enolpyruvate at the third position 
of NAG from phosphosphoenolpyruvate to produce enolpyruvyl UDP-GlcNAc 
(Undecaprenyl N-acetylglucosamine), a reaction catalyzed by MurA (Du et al., 2000). The 
enolpyruvyl UDP-GlcNAc is reduced by MurB into UDP-MurNAc (uridinediphosphate N-
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acetylmuramic acid) (Lovering et al., 2012; Hett and Rubin, 2008). Following this, amino 
acids that make up the stem peptide side chain are sequentially added onto UDP-MurNAc. 
These amino acids are added in the following order: L-alanine, D-glutamine, meso-
Diaminopimelic acid (meso-DAP) and the two terminal D-alanine residues by MurC, MurD, 
MurE and MurF, respectively to form Lipid I, which is converted into Lipid II upon addition 
of the UDP-NAG residues by MurG  (Mahapatra et al., 2005; Hett and Rubin, 2008; Fan et 
al., 1994; Bouhss et al., 2008), figure 1.1.3. Lipid II is translocated across the membrane for 
further remodelling in the periplasm by PG remodelling enzymes. 
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Figure 1.1.3. Diagrammatic representation of the cytoplasmic step of PG biosynthesis. The 
figure shows the conversion of NAG (N-acetyl glucosamine) residues to UDP-MurNac 
(uridinediphosphate N-acetylmuramic acid), followed by addition of the amino acids that 
form the stem peptide side chain which makes up the Lipid I. After this, UDP-NAG 
(uridinediphosphae N-acetyl glucosamine) is added to Lipid I by MurG to form Lipid II 
which is translocated across the plasma membrane for remodelling by PG remodelling 
enzymes in the periplasm. (Lovering et al., 2012). 
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1.5. Periplasmic step of PG biosynthesis 
1.5.1. Hydrolases 
1.5.1.1. Lytic transglycosylases 
Lytic Transglycosylases hydrolyze the internal β,1-4 glyscosidic bonds between the NAM 
and NAG sugar residues (figure 1.1.4) with the same specificity as lysozymes, releasing 1,6-
anhydromuramoyl product consisting of NAG sugar residues linked to the amino acid side 
chain (Scheurwater et al., 2008; Zahrl et al., 2005). The difference between lytic 
transglycosylases and lysozyme is that lytic transglycosylases exhibit exo-lytic activity, only 
cleaving the terminal NAG sugar residues (Höltje et al., 1975). Lytic transglycosylase 
facilitate the formation of large gaps within the PG layer that act as sites for the assembly of 
protein complexes (e.g. Bacterial secretion systems) and related structures such as flagella 
(Koraimann, 2003; Scheurwater et al., 2008). The formation of these gaps is also essential 
for expansion of the existing PG polymer, as these allows for addition of new PG subunits 
(Höltje, 1998). These enzymes also play an essential role, together with amidases, at the 
septum to allow for efficient and regulated cell division (Heidrich et al., 2002). In addition, 
they are involved in PG recycling, wherein  the  NAM containing PG units released after 
hydrolysis are in turn taken up by the cell for recycling (Park and Uehara, 2008; Lee et al., 
2009). Lytic transglycosylases are involved in β-lactam antibiotic resistance as the 1,6, 
anhydro-muropeptide product that they produce is responsible for the induction of 
βlactamase (Tayler et al., 2010; Hanson and Sanders, 1999; Korsak et al., 2005; Jacoby, 
2009). Lytic transglycosylases are also responsible for PG derived cytoxicity in host cells 
and interact with secretion systems involved in the export of virulence factors (Cloud and 
Dillard, 2002; Höppner et al., 2005) 
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Figure 1.1.4. The site of action of PG remodelling enzymes in mycobacteria. The image 
shows that PG is remodelled by hydrolase and synthases. The activity of the PG remodelling 
enzymes is tightly regulated to ensure normal growth and survival of mycobacterial cells. 
(Machowski et al., 2015).  
 
1.5.1.2. Resuscitation promoting factors 
Resuscitation promoting factors (Rpfs) are a group of secreted proteins with hydrolytic 
activity that targets the β,1-4 glycosidic bonds within the PG backbone (Vollmer et al., 2008; 
Machowski et al., 2014), figure 1.1.4. These proteins contain a lysozyme like domain 
(Cohen-Gonsaud et al., 2004), suggesting that they function as Lytic transglycosylases. 
Consistent with this, a recent study demonstrated that Rpf-mediated cleavage of purified PG 
yielded 1,6-anhydro-muropeptides (Nikitushkin et al., 2015). M. smegmatis encodes four 
Rpf homologues (designated as MSMEG_5700, MSMEG_5439, MSMEG_4643, 
MSMEG_4640) and M. tuberculosis has five Rpf homologues (designated [rpfA] Rv0867c, 
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[rpfB] Rv1009, [rpfC] Rv1884c, [rpfD]  Rv2389c, [rpfE]  Rv2450c) (Machowski et al., 
2014).  Despite the high level of genetic multiplicity, a series of studies have implicated the 
catalytic activity of Rpfs in a variety of processes. These include: (I) facilitating normal cell 
division through spontaneous association of RpfB (MSMEG_5439) with RipA (an 
endopeptidase) at the division site (Hett et al., 2007) (II) reactivation of bacterial growth 
during infection, through the resuscitation of dormant bacteria (Kana et al., 2008; Kana and 
Mizrahi, 2008; Nikitushkin et al., 2015) and (III) a role in M. tuberculosis virulence during 
acute infection in the murine model of TB infection (Kana et al., 2008; Biketov et al., 2007).  
An interesting aspect of the physiological role of Rpfs, is their predicted association with 
reactivation of dormant bacteria that remain viable but non-culturable, a phenomena that was 
first demonstrated in Micrococcus luteus (Mukamolova et al., 1998). It is estimated that one-
third of the world’s population harbours latent TB infection (LTBI), a form of infection that 
was hypothesized to be associated with dormant M. tuberculosis and reactivation of disease 
in these individuals was ascribed to reactivation of growth in dormant organisms (Kana and 
Mizrahi, 2010). Whilst it is tempting to speculate that Rpfs play a role in this process during 
TB disease in humans, no definitive evidence has been presented that associated LTBI with 
dormant mycobacteria. Moreover, the mechanisms used by Rpfs to reactivate dormant 
bacteria is unknown but it is hypothesized that the PG-derived muropetides released by Rpfs, 
act as signalling molecules, initiating a signal transduction cascade through association with 
the protein kinase B (PknB) (Kana and Mizrahi, 2010; Shah et al., 2008). A detailed 
understanding of the mechanisms of reactivation in dormant bacteria is paramount, 
considering the large proportion of the global population that carries LTBI, a collective that 
poses a serious public health risk. 
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1.5.1.3. Amidases  
Amidases are zinc containing metalloenzymes that cleave the bond between L-Alanine and 
MurNAc, releasing the stem peptide from the PG backbone, figure 1.1.4. These enzymes are 
specifically involved in cleavage of the septum and separation of daughter cells during the 
final stages of cell division (Bernhardt and de Boer, 2003; Höltje and Heidrich, 2001 
Heidrich et al., 2001; Heidrich et al., 2002). Amidases are not solely present in bacteria, but 
have also been found in eukaryotic and viral species and are further classified into two 
subgroups; amidase_2 (PF01510) or amidase_3 (PF01520) containing proteins (Vollmer et 
al., 2008).   
1.5.1.4. N–Acetyl-β-D-glucosaminidases 
N–Acetyl-β-D-glucosaminidases are hydrolases which cleave the bonds between the NAG 
and NAM sugar residues. This group of proteins have received little attention in their role in 
bacterial physiology and PG remodelling. 
1.5.2. PG synthases 
1.5.2.1. L,D Transpetidases  
L,D transpetidases (Ldt) catalyse peptidoglycan cross-linking between adjacent PG subunits. 
They are specifically involved in the formation of the 3 3 cross-links (figure 1.1.4) by 
hydrolysing the D-Ala-meso-DAP bond of the donor pentapeptide stem and transfers the 
peptide bond to the adjacent side chain meso-DAP of the tripeptide acceptor stem (Erdemli 
et al., 2012). In mycobacteria this specific type of cross-linking within the PG layer was first 
observed in M. smegmatis (Wietzerbin et al., 1974). Subsequent analysis revealed that 
approximately 80% of the peptide crosslinks are 3 3 cross-links, with remainder consisting 
of 4 3 crosslinks, which are synthesized by another distinct group of PBPs (discussed in 
section 1.5.2.2) (Lavollay et al., 2008; kumar et al., 2012). In E. coli, the 3 3 PG cross-
links comprise between 3 and 10% of all cross-linked (Pisabarro et al., 1985) and in this 
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context, the high percentage of 3 3 cross-links in M. tuberculosis highlights an important 
role of this specific type of bond during TB pathogenesis.  M. tuberculosis encode for five 
Ldt (designated LdtMt1-LdtMt5), all of which are susceptible to carbapenem treatment in vitro  
(Kumar et al., 2012; Dubée et al., 2012). Carbapenems are a group of β-lactam antibiotics 
wherein the carbon at postion 4 of the thyazalidinic moiety is replaced by sulfone (Bonfiglio 
et al., 2002; Nicoletti et al., 2002). Deletion of LdtMt2 results in morphological defects 
accompanied by reduced virulence and increased susceptibility to amoxicillin during disease 
progression (Gupta et al., 2010). LdtMt1 and LdtMt2 both play a role in virulence, growth and 
maintenance of bacterial cell surface morphology, cell size and shape (Schoonmaker et al., 
2014). The high abundance of 3 3 peptide cross-links in mycobacteria and the sensitivity 
of the enzymes that synthesize them to carbapenem, provides a novel area for the 
development of new drugs that target PG cross-linking.    
1.5.2.2. Penicillin binding proteins (PBPs)  
PBPs are a group of structurally related proteins that have the ability to recognize and bind 
β-lactam molecules, such as penicillin (Ghosh et al., 2008; Mottl and keck, 1991). They are 
classified into two distinct groups; Low Molecular Weight PBPs (LMW PBPs) or High 
Molecular Weight PBPs (HMW PBPs) depending on their electrophoretic mobility as 
examined by SDS PAGE (Ghuysen, 1991; Spratt, 1977; Spratt 1983). 
The HMW PBPs share a common structural organisation with three distinct domains, the 
cytoplasmic tail, a membrane anchoring transmembrane domain and the two catalytic 
transglycosylase and transpeptidase domains (Lovering, et al., 2007; Macheboeuf et al., 
2006; Goffin and Ghuysen, 2002). These proteins are generally targeted to the cell wall 
facing the outer surface of the cytoplasmic membrane where PG remodelling occurs 
(Lovering et al., 2007; Macheboeuf et al., 2006; Goffin and Ghuysen, 2002). The HMW 
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PBPs are further classified into two subgroups: Class A PBPs with both transglycosylase 
(catalysing cross-linking of the glycan sugar component of PG subunits) and transpeptidase 
activity (catalysing cross-linking between stem peptides of adjacent PG strands) (Ghosh et 
al., 2008; Romeis and Höltje, 1994; Lovering et al., 2007) and Class B PBPs with a single 
transpeptidase domain (Höltje, 1998; Machowski et al., 2014). The N-terminal domain is 
used in the classification of these two groups of proteins as either Class A or B HMW PBPs. 
The transglycosylase and transpeptidase domain of Class A HMW PBPs are positioned near 
the N- and C-terminus respectively (Ghosh et al. 2008; Romeis and Höltje, 1998; 
Machowski et al., 2014).  
The Class B HMW PBP lack catalytic activity at the N-terminal domain, possessing only the 
transpeptidase domain at the C-terminal end (Höltje, 1998; Ghosh et al., 2008; Romeis and 
Höltje, 1998; Machowski et al., 2014). The N-terminal domain of Class B HMW PBPs is 
predicted to interact with various proteins that regulate bacterial cell morphogenesis (Höltje, 
1998). In mycobacteria, the class A HMW PBPs includes PonA1, PonA2 and a second 
homologue of PonA2 annotated as PonA3 in M. smegmatis (Machowski et al., 2014; Patru 
and Pavelka, 2010; Billman-Jacobe et al., 1999). The mycobacterial Class B HMW PBPs 
include PBPA and PBPB and BPB-lipo (Machowski et al., 2014; Sauvage et al., 2008). The 
transpeptidase activity of PBPs is involved in the formation of 4 3 cross-links, figure 
1.1.4. This involves binding of the donor pentapetide side chain by the transpeptidase 
domain, followed by the formation of an acyl-enzyme intermediate complex facilitated by 
the active site serine that attacks the D-Ala-D-Ala bond. The intermediate complex is then 
hydrolysed, followed by the transfer of the peptide bond to the adjacent side chain meso-
DAP of the tripeptide acceptor stem to form 4 3 cross-links (McDonough et al., 2002; 
lovering et al., 2012)  
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The second group of PBPs is the LMW PBPs, also referred to as Class C PBPs, which can 
be further categorized into 3-subgroups using E. coli as the representative species. These 
include the monofunctional DD-Carboxypeptidase (DD-CPases), the β-lactamases (Ghuysen, 
1996; Massova and Mobashery, 1998; Navratna et al., 2010) and the PBP4, sub-family of 
bifunctional LMW PBPs with both DD-CPase and transpeptidase domains (Nelson and 
Young, 2001). The LMW PBPs share a common structural organisation consisting of a 
penicllin binding domain and a transmembrane segment for membrane anchoring at the C-
terminus (Jacoby, 2009). This MSc is focused on class C PBPs, particularly the 
characterization of mycobacterial DD-CPases. 
1.5.2.3. DD-Carboxypeptidases 
DD-CPases are acyl serine transferases that retain signature motifs such as the Ser-Xaa-Xaa-
Lys, Ser-Xaa-Asn and Lys-Thr-Gly triad (Nicholas et al., 2003; Goffin and Ghuysen, 1998). 
This group of proteins is involved in the final periplasmic stage of PG biosynthesis. They 
regulate the level of PG cross-linking by hydrolyzing the terminal D-Alanine from the 
pentapeptide side chain of nascent PG subunits, producing a tetrapeptide stem that cannot act 
as a donor for PG crosslinking (Strominger, 1969; Lawrence and Strominge, 1970; Leyh-
Bouille et al., 1972), figure 1.1.4.  The LMW PBPs, as demonstrated in E. coli possess DD-
CPases activity, but their biological significance has not been demonstrated in various 
species (Ghosh et al., 2008; Nelson and Young, 2000). Many organisms harbour a 
multiplicity of DD-CPases, which are predicted to be functionally redundant in E. coli, which 
codes for at least 12 PBPs, of which 4 possess DD-CPases activity (Mossova and Mobashery, 
1998; Holtje, 1998; Denome et al., 1999; Sauvage et al., 2008). Consistent with this notion, 
deletion of individual DD-CPases in E. coli did not result in growth defects. However, 
combinatorial deletion of the different LMW PBPs implicated PBP5 (encoded by dacA) to 
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be important in maintaining normal bacterial cell shape (Nelson and Young, 2001; Holtje, 
1998). PBP5 in E. coli is further implicated in regulating bacterial cell elongation, due to the 
observation that deletion of PBP2 inhibits cylindrical PG synthesis during growth thus 
producing spherical cells, a phenotype reversed by ectopic expression of PBP5.  PBP5 is 
also implicated in mediating cell division as demonstrated by the inability to separate 
daughter cells in a PBP5-AmiC double mutant (Priyadarshini et al., 2006)  
Bacillus subtilis, a gram positive rod-shaped model organism encodes four DD-CPase 
homologues (PBP5 encoded by dacA and dacB, PBP4a and DacF, Popham et al., 1999; 
Atrih et al., 1999; Pedersen et al., 1998). In this organism, PG maturation is mediated by 
DacB (Popham et al., 1999; Atrih et al., 1999; Pedersen et al., 1998) and synthesis of the 
spore cortex PG in matured B. subtilis spores is mediated by DacA and DacF respectively 
(Pedersen et al., 1998; Popham et al., 1999). 
The observed genetic multiplicity with DD-CPases in both E. coli and B. subtilis, and the 
lack of these proteins in the genome of other organisms such as Caulobacter cresecentus and 
Helicobacter pylori (Koyasu et al., 1980; Krishnamurthy et al., 1999; Ghosh et al., 2008), 
suggests they are most likely individually non-essential with overlapping functions. This 
would explain their accessory roles in bacterial elongation and division, in E. coli and B. 
subtilis. In mycobacterial species, DD-CPases are relatively uncharacterized and this study 
will focus on shedding light on physiological function of mycobacterial DD-CPase 
homologues.  
1.6.1. Mycobacterial DD-CPases 
As with other organisms, mycobacteria have multiple DD-CPases homologues. M. smegmatis 
has four DD-CPase homologues (designated MSMEG_1661, MSMEG_2432/3 and 
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MSMEG_6113, Machowski et al., 2014). Currently, a single study has been conducted on 
M. smegmatis DD-CPase by Bansal et al., (2015), which focused on MSMEG_2433 and 
demonstrated that MSMEG_2433 actively binds fluorescent penicillin, a characteristic of 
PBPs, and that heterologous expression of MSMEG_2433 rescues the cell morphology 
defects of the septuple E. coli mutant generated by  Ghosh & Young, (2003), lacking a 
combination of various PBPs. Furthermore, heterologous expression of MSMEG_2433 in 
the suptuple mutant restored β-lactam antibiotic resistance. Purified MSMEG_2433 
displayed ability to hydrolyse artificial PG substrates and also deacylate β-lactam antibiotics. 
M. tuberculosis encodes three DD-CPase homologues (designated Rv2911, Rv3330 and 
Rv3627c). Bourai et al., (2012) revealed a role for Rv2911 in maintaining various cellular 
processes when ectopically expressed in M. smegmatis including colony morphology (see 
results and discussion). Furthermore, they demonstrated that deletion of Rv2911 from wild 
type M. tuberculosis affects bacterial growth in acidic media at low oxygen tensions, 
accompanied by increased survival in ThP-1 cells (Boura et al., 2012). These two studies 
implicate mycobacterial DD-CPases in regulating various cellular processes but do not 
provide insight on functional redundancy or possible roles in regulating cell wall synthesis. 
Cell division and elongation are tightly regulated, and the effectors of both processes exert 
their effect through interaction with various partners (Singh et al., 2006; Kieser, and Rubin, 
2014). As such, it is unclear whether the mycobacterial DD-CPase homologues act as single 
enzymes or exert their function through interaction with various partners, as observed for 
other PBPs. Additionally; the mycobacterial DD-CPase homologues remain uncharacterized. 
Considering this, the specific aims and objectives of this MSc are listed below.  
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1.7.1. Hypothesis 
It is hypothesized that Mycobacterial DD-CPases play important roles in cell elongation and 
division, possibly through interaction with various proteins. It is further speculated that there 
is some degree of overlap of function between the multiple DD-CPase homologues present in 
M. tuberculosis. 
1.8. Aims and objectives of this study 
1.8.1. Study aims 
I. To identify putative interacting partners for MSMEG_2433 and MSMEG_6113. 
These two proteins were chosen based on the observation in our laboratory that the 
former was expressed in high transcript abundance and the latter was essential for 
growth (C.S Ealand and B. Kana, unpublished) 
II. To interrogate the functionality (redundancy vs. specialist function) of the M. 
tuberculosis DD-CPases through ectopic expression in wild type M. smegmatis and 
M. tuberculosis H37RvS. 
1.8.2. Study objectives  
I. To construct two bait vectors carrying MSMEG_2433 and MSMEG_6113 fused to 
mycobacterial dihydrofolate reductase fragment 3 in pUAB400. These will serve as 
the bait vector. 
II. To design a genomic DNA library with overlapping fragments with a size range of 
0.5-5.0 kbps, which will be fused to the mycobacterial dihydrofolate reductase 
fragment 1 and 2 in pUAB300. This will serve as the prey for assaying protein 
interaction.   
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III. To assay protein interaction of the baits (MSMEG_2433 and MSMEG_6113) against 
the prey (genomic DNA library) using the mycobacterial Protein Fragment 
Complementation assay (mPFC). 
IV. To sequence and identify putative interacting partners of MSMEG_2433 and 
MSMEG_6113. 
V. To clone Rv2911, Rv3330 and Rv3627c into pSE100 for ectopic expression in wild 
type M. smegmatis and M. tuberculosis.  
VI. To assess the following in the heterologous M. smegmatis and M. tuberculosis 
strains: 
 Bacterial colony morphology 
 Bacterial sliding  
 Biofilm formation 
 Growth kinetics 
 Cell surface morphology by scanning and transmission electron microscopy 
VII. To create C-terminally tagged rseGFP derivatives of M. tuberculosis DD-CPases.  
VIII. To ectopically express the fusion proteins in wild type M. smegmatis and monitor 
cellular localization of these proteins in the heterologous strain.  
2. Materials and methods  
2.1.1. Plasmids used and constructs generated in this study 
The plasmids and strains used in this are listed in table 2.1.1 and 2.2.2 respectively.  
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Table 2.1.1. Plasmid generated and/or used in this study.  
Plasmid Genotype Source/Reference 
pUAB300 
E. coli-Mycobacterium shuttle plasmid 
carrying the mDHFR fragment 1 and 2, 
together with the glycine linker; Hyg
r
 
Singh et al., (2006) 
pUAB400 
E. coli-Mycobacterium shuttle plasmid 
carrying mDHFR fragment 3; Kan
r
 
Singh et al., (2006) 
pSE100 
E. coli-Mycobacterium shuttle plasmid 
carrying PsymctetO tetracycline regulated 
operator; Hyg
r Erhrt et al., (2005) 
pUAB3145 
Derivative of pUAB300 carrying the 
complete MSMEG_3145 open reading 
frame; Hyg
r
 
This study 
pUAB5439 
Derivative of pUAB400 carrying the 
complete MSMEG_5439 open reading 
frame; Kan
r 
This study 
pUAB2433 
Derivative of pUAB400carrying the 
complete MSMEG_2433 open reading 
frame; Kan
r
 
This study  
pUAB6113 
Derivative of pUAB400 carrying the 
complete MSMEG_6113 open reading 
frame; Kan
r This study 
pSE2911 
Derivative of pSE100 carrying the Rv2911 
gene; Hyg
r
 
This study 
pSE3330 
Derivative of pSE100 carrying the Rv3330 
gene; Hyg
r
 
This study 
pSE3627c 
Derivative of pSE100 carrying the Rv3330 
gene; Hyg
r This study 
pSE2911-
rseGFP 
Derivative of pSE100 carrying Rv2911 
gene with a C-terminal rseGFP; Hyg
r
 
This study 
pSE3330-
rseGFP 
Derivative of pSE100 carrying Rv3330 
gene with a C-terminal rseGFP; Hyg
r
 
This study 
pSE3627c-
rseGFP 
Derivative of pSE100 carrying Rv3627c 
gene with a C-terminal rseGFP; Hyg
r
 
This study  
    Kan
r
, kanamycin resistance; Hyg
r
, hygromycin resistance.  
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Table 2.1.2. Strains used and/or generated in this study. 
Strain Description  Source/Reference 
Escherichia coli 
DH5α 
SupE44 ΔlacU169 hsdR17 recA1 endA1 
gyrA96 thi-1 relA1 
Promega, 
Madison, WI 
mc
2
155 
High frequency transformation mutant 
of M. smegmatis ATCC 607 
Snapper et al., 
1990 
H37RvS 
Laboratory H37Rv strain Ioerger et al., 2010 
mc
2
(pSE100) 
Derivative of mc
2
155 expressing the 
pSE100 vector, Hyg
r This study 
mc
2
(pSE2911) 
Derivative of mc
2
155 ectopically 
expressing Rv2911 from pSE2911 
vector, Hyg
r 
This study 
mc
2
(pSE3330) 
Derivative of mc
2
155 ectopically 
expressing Rv3330 from pSE3330 
vector, Hyg
r
 
This study 
mc
2
(pSE3627c) 
Derivative of mc
2
155 ectopically 
expressing Rv3627c from pSE3627c 
vector, Hyg
r
 
This study 
mc
2
(pSE2911-
rseGFP), 
Derivative of mc
2
155 ectopically 
expressing a C-terminal rseGFP-tagged 
derivative of Rv2911, expressed from 
the pSE2911-rseGFP vector; Hyg
r
 
This study 
mc
2
(pSE3330-
rseGFP) 
Derivative of mc
2
155 ectopically 
expressing a C-terminal rseGFP-tagged 
derivative of Rv3330, expressed from 
the pSE3330-rseGFP vector; Hyg
r
 
This study 
mc
2
(pSE3627c-
rseGFP) 
Derivative of mc
2
155 ectopically 
expressing a C-terminal rseGFP-tagged 
derivative of Rv3627c, expressed from 
the pSE3627c-rseGFP vector; Hyg
r
 
This study 
H37RvS(pSE2911), 
Derivative of H37RvS ectopically 
expressing Rv2911 from the pSE2911 
vector; Hyg
r 
This study 
H37RvS(pSE3330), 
Derivative of H37RvS ectopically 
expressing Rv3330 from the pSE3330 
vector; Hyg
r
 
This study 
H37RvS(pSE3627c) 
Derivative of H37RvS ectopically 
expressing Rv3627c from the pSE3627c 
vector; Hyg
r
 
This study 
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H37RvS(pSE100) 
Derivative of H37RvS expressing the 
pSE100 vector, Hyg
r This study 
mc
2
155::pUAB400 
(pUAB300) 
Derivative of mc
2
155 carrying 
pUAB400 integrated at the attP site  and 
pUAB300 an episomal plasmid, 
Hyg
r
Kan
r 
This study 
mc
2
155::pUAB243
3 (pUAB300) 
Derivative of mc
2
155 expressing 
pUAB2433 integrated at the attP site 
and episomal pUAB300, Hyg
r
Kan
r 
This study 
mc
2
155::pUAB543
9(pUAB3145) 
Derivative of mc
2
155 expressing 
pUAB5439 integrated at the attP site 
and episomal pUAB3145; Hyg
r
Kan
r 
This study 
   Hyg
r
, hygromycin resistance; Kan
r
, kanamycin resistance.  
2.2. Bacterial growth conditions  
2.1 Growth conditions for E. coli DH5α and derivatives.  
E. coli DH5α strains were streaked on Luria-Agar (LA) to obtain single colonies. A single 
colony was picked and inoculated into Luria Bertani (LB) or 2xTY at 37
0
C with shaking at 
250 rpm. Derivatives of E. coli DH5α, transformed with plasmids were cultured on LA, LB, 
or 2xTY supplemented with appropriate antibiotics. Recipes for all media used are in the 
Appendix (Appendix F). The antibiotic concentrations used in this study are as follows: 
Hygromycin (Hyg) 200 µg/ml and Kanamycin (Kan) 50 µg/ml. The volume of liquid media 
was adjusted depending on the type of experiment conducted with each strain (e.g. bulk vs. 
small scale DNA extraction). 
2.2.2. Growth conditions for M. smegmatis and M. tuberculosis.  
The wild type mc
2
155 and derivative strains were cultured on Middlebrook 7H10 agar and in 
Middlebrook 7H9 broth, herein referred to as 7H10 and 7H9 respectively. 7H10 was 
supplemented with 0.2% glucose, 0.5% glycerol, 0.085% NaCl. 7H9 was supplemented with 
0.2% glucose, 0.2% glycerol, 0.085% NaCl, 0.05% tween80. In the case of H37RvS and 
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derivative strains, 7H9 was supplemented with OADC (oleic acid albumin dextrose catalase) 
enrichment, 0.2% glycerol and 0.05% tween80 and Middlebrook 7H11 was supplemented 
with OADC enrichment and 0.2% glycerol. A single colony for each strain was picked from 
solid agar and propagated in 7H9 supplemented with the appropriate antibiotics. The mc
2
155 
strain and derivatives were cultured at 37
0
C with shaking at 100 rpm. The H37RvS strain and 
derivatives were cultured at 37
0
C in disposable tissue culture flasks without agitation. 
Antibiotics were used at the following concentrations: Kan 25 µg/ml and Hyg 50 µg/ml.  
2.3. Mycobacterial DNA extractions 
2.3.1. Large scale DNA extraction for PCR.  
The Cetyltrimethylammonium bromide (CTAB) DNA extraction protocol was used for large 
scale DNA extraction from both M. smegmatis and M. tuberculosis strains. The mc
2
155 and 
derivative strains were cultured on solid media to obtain a lawn of cells and the H37RvS and 
derivative strains were cultured in liquid media. Cells were harvested by scraping the lawn 
of cells off the agar plates or by centrifugation (12 470 X g, 10 min) for mc
2
155 and H37RvS 
respectively. The cells were resuspended in 500 µl TE buffer (10 mM tris-HCl pH 8.0, 10 
mM EDTA dissolved in dH2O). Following resuspension, 50 µl lysozyme (10 mg/ml) was 
added to the cells, followed by incubation for 1 hour at 37
0
C. Thereafter, 70 µl SDS (10%) 
and 6 µl proteinase K (10 mg/ml) was added to the mixture, with further incubation at 65
0
C 
for 1-2 hours. Following this, 100 µl NaCl (5M) and 80 µl CTAB/NaCl buffer (4.1 % NaCl, 
10% N-cetyl-N,N, N-trimethyl ammonium bromide dissolved in dH2O) were added, 
followed by mixing and incubation at 65
0
C for 10 min. An equal volume of 
chloroform:isoamyl alcohol (24:1 ratio) was added and mixed by inverting tubes, followed 
by centrifugation (12 470 X g, 5 min). The top aqueous layer was aspirated and transferred 
to a fresh tube, followed by the addition of 0.6 volume isopropanol. The tubes were placed 
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on ice or at -20
0
C for 20 min, followed by centrifugation (12 470 X g, 30 min) to pellet the 
DNA. The DNA pellet was washed with 70% EtOH and dried using an Eppendorf 
Concentrator 530. The lyophilized DNA was resuspended in an appropriate amount of 
nuclease free water and quantified using the NanoDrop ND-1000 Spectrophotometer 
(NanoDrop technologies). To assess the quality of the DNA, an aliquot was electrophoresed 
on 1% agarose gel with molecular weight markers, Appendix (A.1.1.1). Extracted DNA was 
stored at -20
0
C for subsequent use.  
2.3.2. Small scale DNA extraction for genotypic confirmation  
A colony boil protocol was used for small scale DNA extraction. A single colony (either M. 
smegmatis or M. tuberculosis) was resuspended in 10 µl sdH20, followed by addition of 100 
µl chloroform, mixing and incubation at 65
0
C for 15 min. Thereafter, the mixture was 
centrifuged (12 470 X g, 15 min) and the top aqueous layer extracted without breaking the 
interface. The top aqueous layer was transferred to a fresh tube and 5 µl was used for PCR.  
2.4. E. coli plasmid DNA extraction 
2.4.1. Bulk DNA extraction 
The Nucleobond DNA extraction kit (Macherey Nagel) was used for bulk plasmid DNA 
extraction from E. coli DH5α derivatives. Briefly, the strains were cultured overnight in 50 
ml LB or 2xTy supplemented with the appropriate antibiotics and DNA was extracted 
following instructions specified by the manufacturer. 
2.4.2. Small scale plasmid DNA extraction 
The alkaline lysis miniprep protocol was used for small scale DNA extractions. Strains were 
cultured overnight in 2 ml LB or 2xTY supplemented with the appropriate antibiotics as 
 27 
 
described in section 2.2.1. Cells were harvested by centrifugation (12 470 X g, 5 min) 
followed by resuspension in 100 µl ice-cold solution I (50mM glucose, 25mM Tris-HCl (pH 
8), 10 mM EDTA dissolved in dH2O). Following this, 200 µl freshly prepared solution II 
(1% SDS, 0.2 M NaOH dissolved in sdH2O) was added. The suspension was mixed gently 
by inverting the tubes and incubated on ice for 5 min. Thereafter, 150 µl ice-cold solution III 
(3 M potassium acetate, 11.5% acetic acid dissolved in sdH2O) was added to the sample, 
followed by mixing and incubation on ice for 10 min. The sample was centrifuged (12 470 X 
g, 30 min) and the supernatant transferred to a fresh tube. DNA was precipitated as described 
in section 2.3.1 by adding 0.6 volume isopropanol followed by centrifugation (12 470 X g, 
30 min). The pellet was washed with 70% EtOH and dried as described in section 2.3.1. The 
dried pellet was resuspended in an appropriate volume of nuclease free water and stored at -
20
0
C for subsequent use.  
2.5. DNA clean-up and removal of contaminating proteins  
2.5.1. Sodium acetate precipitation  
Extracted chromosomal or plasmid DNA was sodium-acetate precipitated to remove 
contaminating proteins, salts and other impurities. Briefly, 1/10 volume sodium acetate (3M, 
pH 5.2) was added to the DNA followed by the addition of 3X volume of ice-cold 100% 
EtOH. The sample was mixed and centrifuged (12 470 X g, 30 min). For genomic DNA 
precipitation, 1/10 volume sodium acetate (3 M, pH 5.2) and 3X volume of ice-cold 100% 
EtOH was added to DNA, followed by incubation at -20
0
C for 20 min. After centrifugation 
(12 470 X g, 30 min), the supernatant was discarded and the DNA pellet dried as described 
in section 2.3.1. The dried pellet was resuspended in an appropriate amount of nuclease free 
water and stored at -20
0
C for subsequent use.  
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2.6. Restriction profiling 
Restriction profiling of vector backbones, PCR products and recombinant plasmids 
generated in this study was carried out using restriction enzymes from Fermentas 
(Fermantas), NEB (New England Biolabs) and Roche (Roche Applied Sciences) following 
instructions specified by the manufacturer unless stated otherwise. Briefly, restriction digests 
were carried out in a 10 µl reaction volume with approximately 1 µg DNA, 1 µl buffer, 1 U 
enzyme and made up to 10 µl with nuclease free water. The digests were incubated at 37
0
C 
for 1 hour unless stated otherwise by the manufacturer, before running on a 1% agarose and 
imaging using the Bio-Rad Gel Doc (Bio-Rad). BSA (Bovine serum albumin) was added to 
the restriction digests if necessary, to a final concentration of 10 µg/ml.  
2.7. Agarose gel electrophoresis 
Extracted DNA, PCR reactions and restriction digests were run on a 1 % agarose gel made 
with 1X TAE buffer (1 mM EDTA and 40 mM Tris-acetate). Electrophoresis was conducted 
in 1X TAE buffer at 90 V for 45-50 min using a Bio-Rad electrophoresis tank (Bio-Rad). 
Following every run, the gels were imaged with the Bio-Rad Gel Doc (Bio-Rad). The DNA 
molecular weight markers used in this study are shown in the Appendix (A1.1.1). 
2.8. DNA cloning  
2.8.1. Vector backbone confirmation. 
All the vector backbones were confirmed by restriction profiling with at least 4 enzymes 
before cloning. Briefly, E. coli DH5α derivatives carrying the vector backbone were cultured 
overnight as described in section 2.2.1 for large/small scale DNA extraction. The extracted 
plasmid DNA was verified by restriction profiling as described in section 2.6.  
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2.8.2. PCR reactions.  
Gradient PCR (with annealing temperature range of 70
0
C-80
0
C) was carried out to determine 
the optimal annealing temperature for each primer set. The primer sets used in this study are 
listed in the Appendix (Appendix B). Following the determination of the optimal annealing 
temperature for each primer pair, PCR was carried out with the appropriate controls. The 
controls included the positive control (narB), no template control, no forward primer control, 
no reverse primer control and the test PCR with the template, forward and reverse primers. 
For cloning, PCR was carried out with the high fidelity Phusion DNA Polymerase (NEB). 
PCR reactions were set up to a final volume of 25 µl containing 5X HF buffer, DMSO, 50 
ng template DNA, 0.2 mM dNTPs, 1 µM forward and reverse primer, 2 U high fidelity 
Phusion DNA polymerase enzyme. The cycling conditions were as follows; one cycle of 
initial denaturation (95 or 98
0
C, 4 min), 30-35 cycles of denaturation (95 or 98
0
C, 30 sec), 
annealing (70 to 80
0
C, 45 sec), elongation (72
0
C, 30 sec), one cycle of final elongation 
(72
0
C, 7 min). Following PCR amplification, the amplicon was run on a 1% gel and 
visualized as described in section 2.7.  PCR reactions which yielded the expected DNA size 
were used for cloning.  
2.8.3. PCR and plasmid DNA digestion 
Cloning strategies that employed either a single or two inserts were used in this study. The 
PCR product(s) and vector backbone were digested with selected restriction enzymes listed 
in the Appendix (Appendix B). The restriction digests were set up as described in section 
2.6. Restriction enzymes that shared the same restriction buffer were used concurrently in 
one reaction. For restriction digests with two restriction enzymes that do not share the same 
reaction conditions, sequential digests were set up, which involved digestion with one 
enzyme, DNA clean up as per section 2.5.1, followed by digestion with the second enzyme. 
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Following digestion, DNA was run on a 1% low melting agarose gel for DNA purification 
with agarase as described below.   
2.8.4. Agarase DNA recovery and clean-up for cloning.  
The agarase protocol was used for recovery of DNA from agarose gels for cloning purposes. 
Following restriction digests, the vector backbone and PCR product(s) were run on a low 
melting agarose gel. After electrophoresis, the bands were visualized under UV (ultraviolet) 
light and excised from the gel. Following this, the excised gel slice with the desired band 
was weighed and incubated at 70
0
C until the agarose was completely melted. The melted gel 
was equilibrated at 42
0
C for 5 min and 1 U of Agarase was added per 100 mg of liquefied 
gel, followed by incubation at 42
0
C for 30 min. Thereafter, sodium acetate was added to the 
reaction mixture to a final concentration of 2.5 M. The mixture was placed on ice, followed 
by centrifugation (12 470 X g, 10 min). The supernatant was then transferred to a fresh tube 
and 2.5 volumes of isopropanol was added, mixed and incubated for 1 hour at room 
temperature. After incubation, the DNA was harvested by centrifugation (12 470 X g, 15 
min) and dried as described in section 2.3.1. The pellet was resuspended in an appropriate 
volume of nuclease free water and stored at -20
0
C for subsequent use.  
2.8.5. Dephosphorylation of plasmid DNA 
Plasmid DNA was dephosphorylated to remove phosphate groups at the 5’ end of linearized 
plasmid DNA with Antartic Phopshatase (NEB) as per manufacturer’s instructions. This was 
done to prevent self-ligation of the vector backbone during cloning.  
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2.8.6. DNA ligations  
Ligations of PCR product(s) into plasmid DNA was carried out using the Fast-link DNA 
ligation Kit (Epicentre) following instructions specified by the manufacturer. For increased 
ligation efficiency, different ligation ratios (molar ratio of vector: insert) were used. The 
standard ligation ratios used were 1:1, 1:3, 1:5 (vector: insert) for 2-way cloning and 1:1, 
1:3:3 and 1:5:5:5 (vector: insert) for 3-way cloning.  These ratios were adjusted depending 
on the concentration of insert recovered from gel purification. The concentration of the 
vector DNA was kept at 50 ng for all ligations. The following formula was used to calculate 
the amount of insert required for a 1:1 ratio with 50 ng of vector backbone. 
ng of insert = 
 
The final volume for each ligation was kept between 15-20 µl. The ligations were incubated 
at room temperature for 1-2 hours. Following incubation, the ligase was heat inactivated 
(70
0
C, 15 min).  
2.9. Preparation and transformation of chemically competent E. coli DH5α 
2.9.1. Preparation of chemically competent E. coli DH5α 
Chemically competent E. coli DH5α was prepared as follows: A single colony was 
inoculated into 5 ml LB or 2xTY and cultured overnight at 37
0
C with shaking at 250 rpm. 
Fresh 100 ml LB or 2xTY was inoculated with 1 ml of pre-culture and incubated under the 
same conditions. The optical density (OD600) was monitored until log phase (OD600= 0.5-0.9) 
and cells were harvested by centrifugation (3 901 X g, 3 min, 4
0
C). The cells were gently 
resuspended in 20 ml ice-cold CaCl2 (0.1 M) and placed on ice for 20 min. This procedure 
was repeated and following two washes, the cells were resuspended in 4 ml ice-cold CaCl2 
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(0.1 M). For increased transformation efficiency, competent cells were placed on ice for 2 
hours before transformation.  
2.9.2. Transformation of chemically competent E. coli DH5α 
DNA ligations prepared as described in section 2.8.6 were mixed with 100 µl of freshly 
prepared competent cells and placed on ice for 15 minutes. Cells were transformed by heat 
shock (42
0
C, 90 sec) and immediately placed on ice for 5 min, followed by the addition of 
750 µl LB or 2xTY. The transformation reactions were transferred to a 37
0
C incubator with 
shaking at 250 rpm for
 
1 hour, to allow for expression of the antibiotic selectable marker. 
Thereafter, cells were harvested by centrifugation (12 470 X g, 1 min), resuspended in 100 
µl LB or 2xTY and plated on LA supplemented with the appropriate antibiotic.  The plates 
were incubated overnight at 37
0
C and single colonies picked for screening of putative 
positive clones as described below, section 2.10.1. 
2.10. Screening and confirmation of positive clones  
2.10.1. Screening for putative clones  
Putative positive clones were screened as follows: Plasmid DNA from selected transformed 
colonies was extracted using the small scale alkaline lysis miniprep as described in section 
2.4.2. Clones were screened with a single enzyme first and a single positive clone, which 
yielded the expected band size following screening with a single enzyme, was further 
verified by restriction profiling as described in section 2.6 with at least four restriction 
enzymes. Following restriction profiling, the insert was sequenced to ensure that no 
mutations were introduced during the PCR and cloning steps.  
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2.10.2. Sequencing  
The constructs were sent to the Stellenbosch University DNA sequencing facility for 
sequencing. Following DNA extractions with the Nuclobond Plasmid extraction kit, the 
constructs were sequenced using the BigDye Terminator V3.1 sequencing kit (Applied 
Biosystems) following instructions supplied by the manufacturer.  
2.11. Transformation of M. smegmatis 
2.11.1. Preparation of electro-competent mc
2
155  
Cells were grown to log phase (OD600 = 0.5-0.9) and harvested by centrifugation (2 360 X g, 
10 min, 4
0
C). The cells were then washed three times by gentle resuspension in 10 ml ice-
cold 10% glycerol with harvesting by centrifugation (2 360 X g, 10 min, 4
0
C) between 
washes. Following these washes, the cells were resusepended in 4 ml ice-cold 10% glycerol 
and used immediately.  
2.11.2. Transformation of electro-competent mc
2
155  
For transformation, 400 µl of electro-competent cells were transferred to a 0.2 cm 
electroporation cuvette (Bio-Rad) together with plasmid DNA obtained following 
confirmation of the construct by restriction digest and sequencing. The Gene PulserX cell 
(Bio-Rad) was used for electroporation and the conditions were as follows: 2.5 KV, 25 µF 
and 1000 Ω with a path length of 0.2 cm. Following pulsing, cells were immediately rescued 
with 800 µl LB or 2xTY for 3 hours or overnight at 37
0
C with shaking at 100 rpm. The 
rescued cells were plated on 7H10 agar supplemented with the appropriate antibiotic. The 
plates were incubated for at least 3-4 days to allow colonies to emerge.  
 
 34 
 
2.12. Transformation of H37RvS 
12.2.1. Preparation of electro-competent H37RvS  
Electro-competent M. tuberculosis H37RvS cells were prepared as follows. Cultures were 
grown to log phase as described in section 2.2.2 and the cells harvested by centrifugation (2 
360 X g, 10 min). The pelleted cells were washed three times with room temperature 10% 
glycerol. Following the last wash, cells were resuspended in 4 ml of room temperature 10% 
glycerol and immediately used for electroporation with The Gene PulserX cell (Bio-Rad).  
2.12.2. Transformation of electro-competent H37RvS  
Plasmid DNA was damaged by UV irradiation (100 mJ cm
-2
) using the Uvitech CL503G, 
which allows for increased transformation efficiencies. Following UV irradiation, 400 µl of 
electro-competent H37RvS, together with damaged DNA, was transferred to 0.2 cm 
electroporation cuvettes (Bio-Rad) and pulsed as described in section 2.11.2. Thereafter, 
cells were immediately rescued with 800 µl 7H9, followed by incubation overnight at 37
0
C 
without shaking. The transformations were plated on 7H11 supplemented with the 
appropriate antibiotic and incubated at 37
0
C for at least 5 weeks for colonies to emerge.  
2.13. Genotypic confirmation of recombinant strains   
The mc
2
155 and H37RvS and their derivatives were confirmed as follows. After 
transformation, a single strain was picked and DNA extracted by colony boil described in 
section 2.3.2. PCR with Fast-start Taq DNA polymerase (Roche) was used for genotypic 
confirmation with gene specific primers listed in the Appendix (Appendix B).  PCR 
reactions were set up in a final volume of 25 µl, with the following contents: 1X 
recommended PCR buffer supplied by the manufacturer, 1X GC rich solution, dNTPs to a 
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final concentration of 0.2 mM, reverse and forward primers each at a final concentration of 1 
µM, DNA template (5 µl) and 0.2 U Fast-start Taq polymerase. The PCR cycling conditions 
were the same as described in section 2.8.2.  
2.14. Genomic DNA library construction 
2.14.1. Genomic DNA extraction and restriction digest 
The mc
2
155 genomic DNA was extracted using the CTAB method as described in section 
2.3.1 and run on a 1% gel along with molecular weight marker to determine quality. DNA 
was quantified with the NanoDrop ND-1000 Spectrophotometer (NanoDrop Technologies). 
The library was designed by setting up a 2-fold dilution series of a TaqI restriction enzyme 
digest as follows: A series of reaction mixtures with equal amounts of DNA (8 µg), buffer 
and nuclease free water were set up to final volume of 40 µl. TaqI 10 U from NEB was 
added to the first tube, mixed and a 2-fold serial dilution of the enzyme was carried out. 
Dilution, was carried out to ensure partial digestion of genomic DNA with overlapping 
fragments. The reaction digests were incubated at 37
0
C for 1.5 hours.  Thereafter, the 
enzyme was heat inactivated by incubation at 80
0
C for 20 min. Following this, 5 µl of the 
partial digests was run on a 1% gel as described in section 2.7 to identify a digest with a 0.5-
5.0 kbps fragment size range. The selected digest was sodium-acetate precipitated as 
described in section 2.5.1 and run on a 1% gel to ensure that the fragment size range was still 
between 0.5-5.0 kbps and no shearing had occurred during the clean-up. The prey vector 
(pUAB300) was linearized with ClaI and ligations were carried out using the following 
vector: insert ratio; 1:1, 1:3 and 1:5 and 2:1. A cut and ligate control was also carried out.  
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2.14.2. Preparation of electro-competent E. coli DH5α  
A pre-culture of E. coli DH5α was set up by inoculating a single colony into 5 ml 2xTY and 
incubated overnight at 37
0
C with shaking at 250 rpm. The pre-culture was used to inoculate 
100 ml fresh 2xTY, which was allowed to grow to log-phase. Cells were placed on ice for 10 
min followed by centrifugation (3 901 X g, 3 min, 4
0
C). The cells were gently washed three 
times in ice-cold 10% glycerol, with harvesting by centrifugation (308.1 X g, 10 min, 4
0
C) 
between washes. After the final wash step, cells were resuspended in 4 ml ice-cold 10% 
glycerol and immediately used for transformation.  
2.14.3. Transformation of electro-competent E. coli DH5α 
The ligation reactions and 40 µl of electro-competent cells were transferred to a 0.1 cm 
electroporation cuvette (Bio-Rad) and pulsed with the Gene PulserX cell (Bio-Rad) with the 
following conditions: 1.8 KV, 600 Ω, 10 µF and a path length of 0.1 cm. Following 
electroporation, cells were immediately recovered in 800 µl 2xTY for 1 hour at 37
0
C and 
plated on LA supplemented with the appropriate antibiotic. The plates were incubated at 
37
0
C overnight. The next day, 10 colonies were randomly picked and digested for 
confirmation for the presence of insert (data not shown). Following this, cells were scraped 
off and plasmid DNA extracted using the nucleobond Plasmid Purification kit, as described 
in section 2.4.1. This constituted the plasmid DNA for genomic library.  
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2.15. Identification of the respective MSMEG_2433 and MSMEG_6113 putative 
interacting partners 
2.15.1 Assaying for putative interacting partners for MSMEG_2433 and 
MSMEG_6113. 
The interaction between the proteins encoded on pUAB(3145) (RipA) and pUAB::5439 
(RpfB) served as the positive control for this study. To confirm this, mc
2
155 was 
transformed with these two vectors and plated on TRIM (Figure 3.1.9). For negative controls 
the empty pUAB300 vector was used in conjunction with the pUAB6113 and pUAB2433 to 
create two strains, mc
2
::2433 (pUAB300) and mc
2
::6113 (pUAB300) – that displayed no 
growth on plates as expected (Table 3.1.9). The positive control were chosen based on 
experimental data that demonstrated an interaction between MSMEG_5439 (RpfB) and 
MSMEG_3154 (RipA), which results in synergistic degradation of septal peptidoglycan 
(Hett et al., 2007, Hett et al., 2008) (II) The mc
2
::pUAB5439 was generated by co-
electroporation of pUAB5439 and pUAB3145 recombinant plasmids into mc
2
155. The 
mc
2
::pUAB2433 and mc
2
pUAB6113 strains were generated by transformation of mc
2
155 
with pUAB2433 and pUAB6113 respectively. To assay for putative interacting partners, the 
library DNA was introduced into mc
2
::pUAB2433 and mc
2
::pUAB6113 strains by 
electroporation as described in section 2.11.2. After electroporation, cells were rescued as 
with 800 µl 2xTY and plated on 7H10 with Hyg/Kan. Following 3-4 days of incubation, 
cells were scraped off, resuspended in 1 ml 7H9 and plated on 7H10 Hyg/Kan supplemented 
with 7.5 µg/ml Trim (trimethoprim).  Plates were incubated for 7 days and growth was 
scored as positive interaction. A graphical representation of the principles of the mPFC assay 
is shown below, figure 2.1.1 
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Protein X
mDHR F1
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Electroporation
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mDHR F3
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mDHR F1
Protein Y
mDHR F2
No protein interaction
Positive protein interaction
and reconstitution of mDFR
mDHR F3
Protein X
No colony growth on Trim supplemeted plates Colony growth on Trim supplemeted plates
 
Figure 2.1.1. The concept of the mPFC assay. The system requires the introduction of two 
proteins (X and Y) tagged with the mycobacterial dihydroflate reductase fragments (1 and 
2) and fragment 3 respectively. In the case of no protein interaction between the two 
proteins there will be failure to reconstitute the mycobacterial dihydrofolate reductas 
(mDFR) and no growth will be observed on trimethoprim (Trim) supplemented plates. 
Positive interaction between protein X and Y results in the reconstitution of the mDHFR, 
which hydrolyses Trim allowing for colonies to emerge on Trim supplemented plates 
(Singh et al., 2006) 
 
2.15.2. Sequencing and identification of the respective interacting partners 
A colony boil was carried out as described in section 2.3.2 to extract the prey vector carrying 
the respective putative interacting partners. The extracted plasmid DNA was introduced into 
chemically competent E. coli DH5α prepared as described in section 2.9.1. The 
transformants were cultured in 2xTY supplemented with the appropriate antibiotic followed 
by plasmid DNA extraction using the small scale alkaline lysis miniprep protocol as 
described in section 2.2.2 for sequencing. The sequences were analysed using Blastx (), 
Blastn (http://blast.ncbi.nlm.nih.gov/Blast.cgi) 
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and Smart blast (http://blast.st-va.ncbi.nlm.nih.gov/blast/smartblast/) from NCBI. The 
BioCyc (http://biocyc.org/MSME246196/blast.html) data base was also used to analyse 
protein domains (see discussion). 
 
Strategy of the mPFC assay used in this study 
  
Figure 2.1.2. The strategy employed using the mPFC assay to identify putative interacting 
partners for MSMEG_2433 and MSMEG_6113. The genomic DNA library cloned in the 
prey vector was introduced into wild type M. smegmatis together with MSMEG_2433 or 
MSMEG_6113 cloned into the bait vector. Colonies on Hyg/Kan plates were scraped and 
sub-cultured on Trim supplemented solid agar and growth was scored as positive interaction, 
followed by isolation of prey vector plasmid DNA and confirmation of insert by sequencing. 
Genomic DNA  
library 
MSMEG_2433 or  
msmeg_6113 
Clone into prey vector  
(pUAB300) 
Clone into bait vector  
(pUAB400) 
Introduce into  M.  smegmatis 
Grow on  Hyg / Kan 7H11 
Scrape off cells and grow on Trim plate 
Growth scored as positive interaction  
Grow again on Trim plates 
Isolate plasmid prey DNA 
Confirm presence of insert by restriction digest 
Subject sequence to  bioinfarmatic 
analyses to respective protein. 
Sequence insert  
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The resulting sequence was subjected to various bioinformatics analysis to identify the 
putative interacting partners.  
2.16. Phenotypic characterization of recombinant strains  
2.16.1. Assessment of mycobacterial colony morphology 
The heterologous M. smegmatis strains ectopically expressing M. tuberculosis DD-CPase 
homologues and the control strains were grown to log phase (OD600 = 0.5-0.9) and 100 µl 
spotted on 7H10 agar supplemented with the appropriate antibiotic.  The recombinant M. 
tuberculosis H37RvS derivatives ectopically expressing the M. tuberculosis DD-CPase 
homologues were grown similarly to log phase and plated on 7H11 supplemented with the 
appropriate antibiotics. The colonies were imaged using a standard digital camera and 
bacterial cording was assessed using the Zeiss STEMI-2000c dissecting microscope. 
2.16.2. Assessment of mycobacterial biofilm formation  
The air-media interface protocol as published by Ojha et al., (2008) was used for assessment 
of biofilm formation for the M. smegmatis and M. tuberculosis derivatives that ectopically 
express the M. tuberculosis DD-CPase homologues. Cells were grown to stationary phase 
(OD600 = 2.0) and cultures that exceeded an OD600 = 2.0 were adjusted by dilution. The cells 
were washed two times in Sauton’s minimal media (refer to Appendix G), pH 7.3. Following 
the washes, serial dilutions for each strain (10
0
-10
5
) were carried out and 100 µl of each 
dilution, inoculated into 10 ml Sauton’s media in a 6-well microtitre plate. The CFU/ml was 
scored for each dilution to ensure that the amount of inoculum for each strain at each 
dilution is uniform as variations in inoculum could result in aberrant biofilm formation.The 
plates were sealed with biohazard tape to prevent evaporation and incubated at 37
0
C before 
viewing with the Zeiss STEMI-2000c dissecting microscope.  
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2.16.3. Assessment of bacterial sliding motility 
Sliding motility of M. smegmatis derivatives was assayed on semi-solid media as previously 
described by Martinez et al., (2001). Single colonies of each strain were placed on the 
surface of 7H9 solidified with 0.3% agar or agarose (refer to Appendix G). The plates were 
sealed with parafilm and incubated for two weeks at 37
0
C for assessment of bacterial sliding. 
As an alternative, the strains were grown to log-phase (OD600 = 0.5-0.9) and 10 µl of the log-
phase cultures were stab-inoculated into 7H9 solidified with 0.3% agar. The stab-inoculated 
plates were sealed as described above and incubated at 37
0
C for 3 days. Following the 
incubation period, the plates were imaged with the Bio-Rad Gel Doc.  
2.16.4. Assessment of mycobacterial growth  
Growth was determined by monitoring the OD600 and plating for CFU/ml. Growth of the M. 
smegmatis strains was monitored in 7H9 and plating for CFU/ml on 7H10 supplemented 
with the appropriate antibiotic. Growth of the M. tuberculosis strains was assayed in 7H9 
and 7H11 supplemented with the appropriate antibiotic. For M. smegmatis, a pre-culture was 
set up by inoculating 1 ml of freezer stock in 10 ml 7H9. The pre-culture was grown 
overnight at 37
0
C with shaking at 100 rpm to start a growth curve with a starting OD600 = 
0.01. Growth rates were assayed by monitoring the OD600 and plating for CFU/ml at 3-hour 
intervals. For M. tuberculosis H37RvS derivatives, a pre-culture was set up by inoculating 1 
ml freezer stock in 10 ml 7H9 supplemented with the appropriate antibiotics. The pre-culture 
for each strain was grown for 3 days before inoculation into 50 ml fresh media to a starting 
OD600 = 0.05. Growth of the M. tuberculosis H37RvS strains was assayed daily by 
monitoring the OD600 and plating for CFU/ml.    
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2.16.5. Scanning electron microscopy preparation and imaging 
To assess cell surface morphology by scanning electron microscopy (SEM), a growth curve 
for M. smegmatis and M. tuberculosis was started as described above. Cells were harvested 
by centrifugation (3 901 X g, 10 min) at lag, log and stationary phases of growth for SEM.  
The M. tuberculosis cultures were killed by resupension in 100 µl formaldehyde (4%), 
followed by incubation at 37
0
C for 1 hour. The cells were washed twice in 0.1 M PBS 
(Phosphate buffered saline) with centrifugation steps in between washes (3 901 X g, 10 min) 
and the supernatant discarded after the final wash step. Cells were then fixed overnight at 
4
0
C in a fixative solution of 2.5% glutaraldehyde in 0.1 M PBS, pH7.4. Following this, cells 
were washed three times in PBS with centrifugation steps in between (12 470 X g, 10 min) 
and stained with 100 µl osmium (2%) for 1 hour. After staining, cells were washed three 
times in PBS as previously described and samples dehydrated by washing with increasing 
EtOH concentrations (30%, 50%, 70% and 100%) for 2 min. The dehydration step was 
repeated once more with 100% EtOH and the samples were stored in 100% EtOH at room 
temperature for imaging. Samples were then spotted on a filter and coated twice with carbon 
for imaging with the FEI Nova NanoSEM 230 scanning electron microscope 
2.16.6. Transmission electron microscopy preparation and imaging  
Growth curves were started as described in section 2.16.4 and cells were harvested at 
lag, log, and stationary phases of growth for transmission electron microscopy (TEM). 
The M. tuberculosis strains were killed and washed in PBS as described above. Cells 
were then fixed in 500 µl TEM fixative solution (0.1M HEPES, 2.5% glutaradehyde, 
2% formaldehyde and 0.05% ruthenium red) at room temperature for 1 hour. After 
chemical fixation, the samples were washed three times with PBS as described above 
and stained with 100 µl osmium (2%) for 1 hour. The samples were dehydrated with 
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increasing concentrations of EtOH (30%, 50% and 100%). The samples were then 
washed twice in propylene oxide and then transferred to a propylene oxide:resin (1:1 
ratio) solution for 1 hour. Cells were harvested by centrifugation (12 470 X g, 10 min) 
and stored overnight at room temperature in 100% resin (5.62 g araldite, 7.75 epon 812 
and 15 g DDSA). Following overnight incubation, cells were pelleted and transferred to 
fresh resin containing DMP30 accelerator (1:40). The samples were incubated at room 
temperature for one hour followed by incubation at 60
0
C for 48 hours. The solidified 
samples were sectioned with the Relchert Ultracut Ultramicrotome (Leica-Reichert) and 
imaged with Tecnai F20 Transmission Electron Microscope.  
2.17. Fluorescence microscopy  
The M. smegmatis derivatives carrying the rseGFP fusion proteins were cultured to log 
phase (OD600 = 0.5-0.9) in 7H9 supplemented with the appropriate antibiotic. Following this, 
cells were harvested by centrifugation (12 470 X g, 1 min) and washed twice in PBS. 
Thereafter, 3 µl was spotted and spread evenly on cover slips before heat fixation at 60
0
C on 
a heating block for 30 sec. Cells were mounted on slides with fluoromount and allowed to 
dry before viewing with the Zeiss 100x, 1.46 numerical aperture objective mounted to an 
Axio Observer Z1 base. The images were processed using the Zen lite blue edition (2012) 
version 1.1.2.0. Any brightness/contrast manipulations were applied to the entire image and 
not specific sections.  
2.18. Statistical analyses 
The GraphPad Prism 6 was used for statistical analysis of the standard error and P-values 
(Student’s t-test at 95% confidence level) for all assays that required statistical analysis.  The 
P-values illustrate the statistical difference and abbreviated as follows; P<0.01; data is not 
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sdtatisitcally significant, P<0.001; data is moderately significant, P<0.0001; data is strongly 
significant) 
3. Results 
3.1. Protein interaction 
One of the aims of this MSc was to identify putative interacting partners for two M. 
smegmatis DD-CPases, MSMEG_2433 and MSMEG_6113, using the mPFC assay. The 
rationale for choosing these two particular DD-CPases was based on the observation from 
unpublished work (C.S Ealand and B. Kana) in our laboratory demonstrating that 
MSMEG_6113 is essential for growth and that MSMEG_ 2433 is expressed at 
comparatively higher transcript abundance when compared to other DD-CPase-encoding 
genes in M. smegmatis.  The approach in this regard first involved the construction of 
vectors that would serve as positive controls to confirm the accuracy of the read-out. 
Following this, MSMEG_6113 and MSMEG_2433 were cloned into bait vectors, followed 
by construction of a representative genomic DNA library of M. smegmatis to screen for 
putative interacting partners. 
3.1.1. Confirming the efficacy of the mPFC assay by assessing protein-interaction of the 
two peptidoglycan hydrolases, RipA and RpfB  
The mPFC assay uses two vectors; these include an integrating (pUAB400) and episomal 
(pUAB300) plasmid. E. coli DH5α cells carrying the respective vectors were streaked on LA 
supplemented with the appropriate antibiotic and a single colony was picked, cultured 
overnight as detailed in section 2.2.1 for large scale plasmid extraction using the Macherey-
Nagel Nucleobond Plasmid Extraction Kit, following instructions specified by the 
manufacturer. The vectors were verified by restriction profiling with at least four different 
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restriction enzymes. The restriction maps that were obtained are given in the Appendix 
(A.1.1.5 and A.1.1.6) 
The screening procedure required positive controls to confirm functionality of the system. 
For this, we selected the resuscitation promoting factor B (RpfB- a lytic transglycosylase) 
and the Rpf interacting protein A (RipA- an endopeptidase) for the following reasons: (I) A 
series of studies have demonstrated an interaction RpfB and RipA, which results in 
synergistic degradation of septal peptidoglycan (Hett et al., 2007, Hett et al., 2008) (II) Both 
these proteins co-localize to the septum during growth (Hett et al., 2007) (III) These are 
periplasmic proteins and better reflect the cellular location expected for DD-CPases than 
cytoplasmic enzymes (Hett et al., 2008) (IV) Synergistic degradation of cell wall material by 
these two enzymes is expected to release products that allow for reactivation of dormant 
bacteria (Kana et al., 2008; Nikitushkin et al., 2015), further substantiating the physiological 
relevance of their interaction in M. smegmatis.  
RipA and RpfB are encoded by MSMEG_3154 and MSMEG_5439 respectively. These 
genes were PCR amplified with the primer set listed in the Appendix (Appendix B). 
Directional cloning with BamHI+HindIII for RipA and EcoRI+HindIII for RpfB into 
pUAB300 and pUAB400 respectively was carried out as detailed in section 2.8.6. 
Chemically competent CaCl2 E. coli DH5α were transformed with the ligations and 
propagated in LB as detailed in section 2.2.1. The recombinant plasmid DNA from 
transformed colonies was isolated using the small scale alkaline lysis miniprep DNA 
extraction protocol as detailed in section 2.4.2 and putative positive clones were identified 
by screening with a single enzyme. A single putative clone was taken forward and further 
verified by restriction profiling with at least four enzymes and sequencing. The restriction 
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profiles for ripA (MSMEG_3145) and rpfB (MSMEG_5439) cloned into pUAB300 and 
pUAB400 respectively are given figure 3.1.2 and figure 3.1.3 respectively.  
 
  
    
 
 
 
 
 
 
 
 
Figure 3.1.2. Restriction profiling of MSMEG_3145 cloned into pUAB300. (A) Vector map 
of MSMEG_3145 cloned in pUAB300. (B) Restriction profile of MSMEG_3145 cloned into 
pUAB300. Lane 1= Marker IV, Lane 2= Uncut pUAB300, Lane 3= XbaI, Lane 4= BglII, 
Lane 5= PstI, Lane 6= AatII, Lane 7= XhoI. (C) Table showing the expected banding 
patterns for MSMEG_3145 cloned into pUAB300 with the restriction enzymes listed.  
 
Restriction enzyme  Expected molecular weight  
(bps)  
XbaI  6393  
BglII  5251 and 1142  
PstI  5550 and 853  
AatII  3786, 1659 and 948  
XhoI  2718, 2559 and 1116  
B 
B 
A 
C 
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Restriction enzyme  Expected Molecular weight  
(bps)  
EcoRI 5807 
XbaI  3954 and 1853 
XhoI 4921 and 886 
BamHI 3275, 1908 and 624 
 
Figure 3.1.3. Restriction profiling MSMEG_5439 cloned into pUAB400. (A) Vector map of 
RpfB cloned into pUAB400. (B) Restriction profile of MSMEG_5439 cloned into 
pUAB400. Lane 1= Marker IV, Lane 2= Uncut pUAB400, Lane 3= EcoRI, Lane 4= XbaI, 
Lane 5= XhoI, Lane 6= BamHI. (C) Table showing the expected banding patterns for 
MSMEG_5439 cloned into pUAB400 with the restriction enzymes listed. 
 
Co-electroporation of mc
2
155 with the above constructs was carried out as detailed in 
section 2.11.2 to generate the mc
2
::pUAB5439 (pUAB3145) strain carrying both tagged 
derivatives of RpfB and RipA This strain was propagated on solid 7H10 media 
supplemented with Hyg and Kan. To confirm that the selected clone carried the desired gene, 
a colony boil was carried out as detailed in section 2.3.2 for PCR confirmation of the inserts 
using gene specific primers listed in the Appendix (Appendix B). Figure 3.1.4 shows the 
A 
C 
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primer binding sites of the PCR confirmation primers for MSMEG_3145 and 
MSMEG_5439 cloned into pUAB300 and pUAB400 respectively, and PCR confirmation of 
MSMEG_3145 and MSMEG_5439 respectively.  
A.                                                                                                                                                 
 
MSMEG_3145+pUAB300 
6393 bps 
1000 
2000 
3000 
4000 
5000 
6000 
MSMEG_3145_F 
MSMEG_3145_R 
'groEL 
ORF-6'' 
DHFR(1,2) 
Gly6' 
MSMEG_3145 
1495 bps 
'ORF-6 
hygro 
'oriE 
oriM 
    
 
MSMEG_5439+pUAB400 
5807 bps 
1000 
2000 
3000 
4000 
5000 
MSMEG_5439_F 
MSMEG_5439_R 
groEL 
 DHFR(3)' 
MSMEG_5439 
1128 bps 
'ORF-5 
kan (aph) oriE 
attP 
int 
 
B.                                                                    
4254
1
2388
432 5 6 98 107
925
1469
1882
3140
1150
2322
bps
1128
1494
19329
7743
5526
 
Figure 3.1.4. PCR confirmation of strains carrying control vectors. (A) The primer binding 
sites for PCR confirmation are indicated by the green marker arrows. Primer pairs 
(MSMEG_3145_F+MSMEG_3145_R) and (MSMEG_5439_F+MSMEG_5439_R) were 
used for PCR confirmation of MSMEG_3145 and MSMEG_543 respectively. (B) PCR 
confirmation of MSMEG_3145 and MSMEG_5439 cloned into pUAB300 and pUAB400. 
MSMEG_3145 and MSMEG_5439 were PCR amplified with an annealing temperature of 
70
0
C and 72
0
C respectively. Lane 1= Marker IV, Lane 2= narB (positive control), Lane 3= 
No template control, Lane 4= No forward primer control, Lane 5= No reverse primer 
control, Lane 6= MSMEG_3145, Lane 7= No template control, Lane 8= No forward primer 
control, Lane 9= No reverse primer control, Lane 10= MSMEG_5439. 
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To assay for protein interaction, the mc
2
::pUAB5439 (pUAB3145) strain was cultured on 
7H10 Hyg/Kan media supplemented with Trim to a final concentration of 30 µg/ml. It was 
decided to monitor colony growth on a daily basis since the time at which colonies emerge is 
determined by multiple factors including the strength of interaction between two proteins, 
with colonies representing weaker interactions emerging later compared to colonies from 
stronger interactions (Singh et al., 2006).  The culture plates were incubated for 3 days at 
37
0
C, which is generally the time it takes for M. smegmatis colonies to emerge. No growth 
was observed for the mc
2
::pUAB5439 (pUAB3145) strain after the 3 day incubation period 
(data not shown).  
To address this, growth of the mc
2
::pUAB5439 (pUAB3145) strain was monitored for 7 
days. No colony growth was observed following the 7-day incubation period (data not 
shown). Following these unsuccessful attempts, it was hypothesized that the 
mc
2
::pUAB5439 (pUAB3145) strain required additional growth enhancers not contained in 
Middlebrook 7H10 agar. The strain was cultured on Middlebrook 7H11 agar, a modified 
form of 7H10 Middlebrook agar, enriched with casein hydrolysate that supports the growth 
of M. tuberculosis (Cohn et al., 1968). No growth was observed for the mc
2
::pUAB5439 
(pUAB3145) strain on 7H11 Middlebrook agar with the same Trim concentration used 
previously (data not shown). This suggested that a different factor, other than growth 
supplements contained in the media was inhibiting growth of the mc
2
::pUAB5439 
(pUAB3145) strain.  
Given that changing the growth media had no effect, we next hypothesized that the 
concentration of Trim was toxic, preventing growth of the mc
2
::pUAB5439 (pUAB3145) 
strain. To test this, the concentration of Trim was gradually decreased by 5 µg/ml intervals 
from 30 to 10 µg/ml, and when no growth was observed (data not shown), it was further 
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decreased to 7.5 µg/ml, which allowed for growth of the mc
2
::pUAB5439 (pUAB3145) 
strain after 7 days of incubation. The results for the mc
2
::pUAB5439 (pUAB3145) cultured 
on 7.5 µg/ml are reported in figure 3.1.9 and table and table 3.1.1.  
3.1.2. Construction and generation of wild type mc
2
155 genomic DNA library.  
Genomic DNA library construction for studying protein interaction requires highly 
concentrated DNA of good quality. To obtain this, mc
2
155 was cultured on 7H10 solid 
media and incubated as previously described to obtain a lawn of cells. The lawn was scraped 
off and genomic DNA extracted following the large scale genomic DNA extraction protocol 
as detailed in section 2.3.1. The genome of mycobacterial species, including mc
2
155, has a 
high G+C content. Based on this, it was decided to use a restriction enzyme with an A+T 
recognition site, which will cut within the genome less frequently. Higher concentrations of 
restriction endonuclease digest genomic DNA to completion. Hence, setting up a dilution 
series with reducing amount of enzyme results in partial digestion of genomic DNA with 
overlapping fragments of a specific range (in this study, a range of 0.5-5 kbps was 
considered enough for full coverage).  The enzyme of choice was TaqI (recognition site: 
TˆCGA). A restriction digest of the genomic DNA was carried out by serial dilutions of the 
restriction enzyme as described in section 2.14.1 and the dilution series was incubated at 
37
0
C for 1.5 hours. The digests were visualized on a 1% agarose gel to observe which 
dilution of the restriction enzyme resulted in partial fragments, with high a concentration of 
fragments in the range between 0.5 and 5.0 kbps, figure 3.1.5.   
A 6-fold dilution of TaqI (lane 5 in figure 3.1.5) yielded fragments in the range of 0.5-7.0 
kbps. It was decided not carry out a gel extraction procedure since low yields of DNA are 
obtained after gel extraction. Therefore, the digest was sodium-acetate precipitated as 
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described in section 2.5.1. The genomic DNA was resuspended in nuclease free water and 
this constituted the genomic DNA library.  
 
1bps
1882
2 3 4 5 6
19329
5526
2690
7
925
925
 
Figure 3.1.5.  Genomic DNA library of mc
2
155 designed with TaqI. Lane 1: Marker IV, 
Lane 7-3: Partial digests of mc
2
155 genomic DNA. Lane 5 shows a partial digest of genomic 
DNA after a 6-fold dilution of the original restriction digest, with a range of between 7.0 and 
approximately 0.5 Kbps, which was within the expected range.  
The prey vector, pUAB300, was linearized with ClaI for ligation with digested genomic 
DNA as described in section 2.14.1. Electro-competent E. coli DH5α cells were prepared 
with ice-cold 10% glycerol as described in section 2.14.2 and transformed with the library 
ligations using conditions described in section 2.14.3. The transformations were grown on 
LA Hyg plates. A transformation efficiency > 105 is generally considered sufficient for 
coverage (Miller, 1972; Hannah, 1985) and the efficiency from these reactions was estimated 
to be ca. 105 CFU/ml, representing sufficient coverage of the library. All colonies were 
10
-2 
10
-4 
10
-6 
10
-8 
10
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scraped off, followed by a large-scale plasmid DNA extraction, carried out as described in 
2.4.1.  
3.1.3. Cloning and PCR confirmation of MSMEG_2433 and MSMEG_6113 into the 
bait vector, pUAB400 
MSMEG_2433 and MSMEG_6113 were PCR amplified and cloned as detailed in section 
2.8.6. E. coli DH5α was transformed with the ligations and a single putative clone of each 
was verified by restriction profiling and sequencing. The restriction profiles for 
MSMEG_2433 and MSMEG_6113 cloned into pUAB400 are shown in figure 3.1.6 and 
3.1.7 respectively. 
The mc
2
::pUAB2433 and mc
2
::pUAB6113 strains were generated by electroporation of 
these constructs into mc
2
155 section, 2.11.2. A colony boil and PCR confirmation was 
carried out using gene specific primers listed in the Appendix (Appendix B). Figure 3.1.8 
show the primer binding sites of the PCR confirmation primers for MSMEG_2433 and 
MSMEG_6113 cloned into pUAB400 respectively, and PCR confirmation of the 
mc
2
::pUAB2433 and mc
2
::pUAB6113, following transformation of mc
2
155 with the above 
constructs.  
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Figure 3.1.6. Restriction profiling MSMEG_2433 cloned into pUAB400. (A) Vector map of 
MSMEG_2433 cloned into pUAB400. (B) Restriction profile of MSMEG_2433 cloned into 
pUAB400. Lane 1= Marker IV, Lane 2= Uncut pUAB400, Lane 3= HindIII, Lane 4= PstI, 
Lane 5= XhoI, Lane 6= PvuI, Lane 7= SmaI. (C) Table showing the expected banding 
patterns for MSMEG_2433 cloned into pUAB400 with the listed restriction enzymes.  
 
 
 
 
 
 
Restriction enzyme  Expected Molecular weight  
(bps) 
 HindIII  5610 
 PstI  3744 and 1866 
 XhoI  4798 and 812 
 PvuI  4313, 649 and 648 
 SmaI  4005 and 1605 
A B 
C 
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Figure 3.1.7. Restriction profiling of MSMEG_6113 cloned into pUAB400. (A) Vector map 
of MSMEG_6113 in pUAB400. (B) Restriction profile of MSMEG_6113 cloned into 
pUAB400. Lane 1= Marker IV, Lane 2= Uncut pUAB400, Lane 3= XhoI, Lane 4= PstI, 
Lane 5= SphI, Lane 6= SmaI, Lane 7= XbaI. (C) Table showing the expected banding 
patterns for MSMEG_6113 cloned into pUAB400 with the restriction enzymes listed. 
 
 
 
 
 
 
Restriction enzyme  Expected Molecular weight  
(bps) 
XhoI 6122 
PstI 4296 and 1866 
SphI   3737 and 2425 
SmaI  4557 and 1606 
XbaI  4309 and 1853 
A B 
C 
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'ORF-5 
kan (aph) 
oriE 
attP 
int 
groEL 
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Figure 3.1.8. Genotypic confirmation of the bait strains. (A) The primer binding sites for 
PCR confirmation of MSMEG_2433 and MSMEG_6113 cloned into pUAB400.  The primer 
binding sites are indicated by the green marker arrows. Primer pairs 
(MSMEG_2433_F+MSMEG_2433_R) and (MSMEG_6113_F+MSMEG_6113_R) were 
used for PCR confirmation of the respective genes. (B) MSMEG_2433 and MSMEG_6113 
PCR confirmation with annealing temperature at 76
0
C and 70
0
C respectively. Lane 1= 
Marker IV, Lane 2= narB (Positive control), Lane 3= No template control, Lane 4= No 
forward primer control, Lane 5= No reverse primer control, Lane 6= MSMEG_2433, Lane 
7= No template control, Lane 8= No forward primer control, Lane 9= No reverse primer 
control, Lane 10= MSMEG_6113. 
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3.1.4. Screening for interaction partners using the mPFC assay and Trim resistance. 
To screen for putative DD-CPase interacting partners, the bait vector (carrying either 
MSMEG_2433 or MSMEG_6113) were transformed into M. smegmatis as detailed in 
section 2.15.1. Following this, the genomic DNA library carried in the prey vector 
(pUAB300) was introduced into the mc
2
::pUAB2433 and mc
2::
pUAB6113 strains by 
electroporation and the transformations were plated on 7H11 Hyg/Kan solid agar. Colonies 
from 7H11 Hyg/Kan were sub-cultured on 7H11 Hyg/Kan supplemented with 7.5 µg/ml 
Trim and any putative interactions would score as growth on agar plates.  A total of 30 and 
10 putative positive clones were obtained for MSMEG_2433 and MSMEG_6113 
respectively. Table 3.1.1 and figure 3.1.9 summarizes the results obtained for 
MSMEG_2433 and MSMEG_6113 interaction using mPFC assay, including all the controls.   
 
 
Figure 3.1.9. The results obtained using the mPFC assay for screening of putative 
MSMEG_2433 and MSMEG_6113 interacting partners. (A) Wild type mc
2
155 cells only 
negative control. (B) RpfB+RipA positive control. (C) Putative positive interacting partners 
for MSMEG_2433. (D) Putative positive interacting partners for MSMEG_6113. A total of 
30 and 10 putative interacting partners were identified for MSMEG_2433 and 
MSMEG_6113 using the mPFC assay.  
mc2155  
(Negative control) 
mc2::pUAB5439 (pUAB3145) 
(Positive control) 
mc2::pUAB2433 + TaqI library mc2::pUAB6113 + TaqI library 
 
A B 
C D 
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Table 3.1.1. The total number of colonies for each test conducted for screening of putative 
MSMEG_2433 and MSMEG_6113 interacting partners including the appropriate controls 
using the mPFC assay.  
Test 
Positive(-) or 
Negative(+) Total number of colonies  
mc
2
155  
            - 0 
mc
2
155::pUAB6113 (pUAB300)            - 0 
mc
2
155::pUAB2433 (pUAB300)            - 0 
mc
2
155::pUAB5439(pUAB3145)            + 224 
mc
2
155::pUAB2433 + TaqI 
genomic DNA library            + 30 
mc
2
155::pUAB6113 + TaqI 
genomic DNA library             + 10 
 
3.1.5. Identification of the respective MSMEG_2433 and MSMEG_6113 putative 
interacting partners  
The plasmids carried in the above-mentioned positive clones were isolated from M. 
smegmatis, transformed into E. coli DH5α, isolated again and sequenced to determine the 
identity of the inserts. The plasmid inserts were sequenced using the recommended 
sequencing primers for the mPFC system for identification of the putative interacting 
partners (Singh et al., 2006). Due to cost constraints, it was decided to sequence only 15 
putative interacting clones for MSMEG_2433 and 9 sequences were obtained for 
MSMEG_6113.  
To confirm the identity of the respective inserts, the nucleotide sequences obtained were 
analyzed using the Blastx (http://blast.ncbi.nlm.nih.gov/Blast.cgi) search tool from NCBI, to 
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obtain the full length gene of the putative interacting partner.  A list of genes was generated 
by Blastx, and only those with a high percentage identity to the query sequence (viz. 
nucleotide sequences that we obtained and used to search the database) were considered for 
further analysis. To identify the corresponding protein for each respective putative 
interacting partner, the sequences generated through Blastx were further analysed by Blastn 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) also from NCBI. Table 3.1.2 and table 3.1.3 report 
on the respective putative interacting partners identified for MSMEG_2433 and 
MSMEG_6113 respectively using the above mentioned bioinformatics tools. The assay 
revealed that MSMEG_2433 and MSMEG_6113 possibly interact with various proteins, 
including PBPs, identified to be present at the poles of actively growing cells or the 
divisome of dividing cells. These included PonA1, PbpA and PbpB. The assay also revealed 
that the two M. smegmatis DD-CPases possibly interact with transcription (DNA polymerase 
subunit III subunit delta) and translation (RNA polymerase sigma factor E) machinery. 
Hypothetical proteins including several uncharacterized proteins in mycobacteria were also 
identified to possibly interact with MSMEG_2433 and MSMEG_6113.  
To study the domain composition of the putative interacting partners, the sequences from 
Blastn were further analyzed using the BioCyc protein-protein Blast search tool 
(http://biocyc.org/MSME246196/blast.html). Table 3.1.2 and 3.1.3 report on the domain 
composition for the respective proteins identified to possibly interact with MSMEG_2433 
and MSMEG_6113 respectively. The domains for the interacting partners include the 
transpeptidase, glycosyltransferase and penicillin binding domains. These domains are 
contained within the well characterized PG remodelling enzymes, suggestive of a role of the 
two M. smegmatis DD-CPases in effecting PG remodelling at the poles of actively growing 
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cells or the divisome of dividing cells, through associating with the PG remodelling 
enzymes. 
The location of the inserts obtained within the full-length gene was determined. Considering 
the nature of the mPFC assay, it was hypothesized that the insert sequences within the 
putative positive clones probably contain residues that are essential for protein interaction or 
are within a domain involved in protein interaction. To assess this, the Smart Blast search 
tool from NCBI was used. The complete protein sequence of each putative interacting 
partner was analysed through Smart Blast to obtain the domain organization of the entire 
protein. The nucleotide sequence for each positive insert from the library screen was then 
translated using the Expasy translate tool (http://web.expasy.org/translate/), and the output 
sequence was further analysed through Smart Blast (http://blast.st-
va.ncbi.nlm.nih.gov/blast/smartblast/) which gives a summary of the best matches for the 
query sequence, including the conserved domains. The results obtained for each putative 
interacting partner using Smart Blast are reported in table 3.1.2 and table 3.1.3 for 
MSMEG_2433 and SMEG_6113 respectively. The green regions represent the best matches 
for the full length protein sequence. The query sequence is shown in yellow and the 
sequence which best matches the query sequence is indicated in blue. 
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Table 3.1.2.  Putative MSMEG_2433 interacting partners obtained using the mPFC assay. The MSMEG-, NCBIWP- and SMEI- number for 
each putative MSMEG_2433 are listed including the domain organization and the region that the sequenced putative interacting partner occupies 
within the full length protein.  
 
Protein 
MSMEG number 
NCBI WP number 
SMEI number  
                          
Conserved domain 
                                                                                          
Position of putative interacting partner within 
the full length protein sequence  
ATP-dependent zinc 
metalloprotease FtsH 
MSMEG_6105 
WP_003897506.1 
MSMEI_5946 
 
 
Hypothetical protein  
MSMEG_4337 
WP_014878005.1  
MSMEI_4237  
 
 
 
Query 
sequence  
Best 
match  
Reference species 
Best matches  
Query sequence 
Gaps 
Key  
Reference 
species  
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Conserved hypothetical 
protein 
MSMEG_5691 
WP_011730713.1  
MSMEI_5541  
No data obtained  
 
DNA polymerase III 
subunit delta 
MSMEG_6153 
WP_011731078.1   
MSMEI_5996 
 
 
 
Glutamine synthetase 
 
 
 
MSMEG_3561  
WP_014877747.1    
MSMEI_3480 
 
 
Glycosyl 
trasferase/undecaprenyl
-phosphate alpha-N-
acetylglucosaminyltrans
ferase 
MSMEG_4947 
WP_011730204.1  
MSMEI_4819 
 
 
Reference species 
Best matches  
Query sequence 
Gaps 
Key  
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Hypothetical protein 
MSMEG_3858 
WP_003895305.1  
MSMEI_3768 
No data obtained 
 
 
Hypothetical protein 
MSMEG_5299 
WP_014878290.1  
MSMEI_5155 
 No data obtained 
 
 
Penicillin binding 
protein transpeptidase 
domain protein (PbpA) 
MSMEG_0031 
WP_003891359.1  
MSMEI_0033 
 
 
bifunctional penicillin-
binding protein 1A/1B 
ponA1  
MSMEG_6900 
WP_014878797.1 
 MSMEI_6716 
 
 
 
Reference species 
Best matches  
Query sequence 
Gaps 
Key  
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RNA polymerase sigma 
factor E 
MSMEG_1914 
WP_003893296.1 
MSMEI_1874  
 No data obtained  
 
Transglycosylase/ 
penicillin-insensitive 
transglycosylase + 
penicillin-sensitive 
transpeptidase 
MSMEG_6201 
WP_014878017.1 
 MSMEI_4281 
 
 
tRNA pseudouridine 
synthase A 
MSMEG_1527 
WP_014877097.1  
MSMEI_1490 
 
 
UDP-diphospho-
muramoylpentapeptide 
beta-N- 
acetylglucosaminyltrans
ferase (MurG) 
MSMEG_4227 
WP_011729656.1 
 MSMEI_4127 
 
 
Reference species 
Best matches  
Query sequence 
Gaps 
Key  
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UDP-N-
acetylenolpyruvoylgluc
osamine reductase 
(MurB) 
MSMEG_0928 
WP_003892354.1  
MSMEI_0906 
 
 
 
 
  
     
      
 
 
 
 
 
 
 
 
 
Reference species 
Best matches  
Query sequence 
Gaps 
Key  
 65 
 
Table 3.1.3.  Putative MSMEG_6113 interacting partners obtained using the mPFC assay. The MSMEG-, NCBIWP- and SMEI- number for 
each putative MSMEG_6113 are listed, including the domain organization and the region that the sequenced putative interacting partner 
occupies within the full length protein.  
 
Protein 
SMEG number 
NCBI number 
SMEI number  
Conserved domain 
Position of putative interacting partner within the full 
length protein sequence  
Cell division control protein 
Cdc48 
MSMEG_0858 
WP_014877228.1   
MSMEI_1814 
 
 
Coniferyl aldehyde 
dehydrogenase MSMEG_2242 
WP_011728247.1  
 MSMEI_2187 
 
 
 
Reference species 
Best matches  
Query sequence 
Gaps 
Key  
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Enoyl-CoA 
hydratase/isomerase 
MSMEG_0259 
WP_014876714.1  
MSMEI_0251 
 
 
Conserved hypothetical 
protein   
MSMEG_6112 
WP_011731046.1  
MSMEI_5953 
No data obtained  
 
Hypothetical protein 
MSMEG_0610 
WP_014878763.1  
MSMEI_6623 
No data obtained  
 
Hypothetical protein 
MSMEG_0365 
WP_011726883.1 
 MSMEI_0358 
 
 
Reference species 
Best matches  
Query sequence 
Gaps 
Key  
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Hypothetical protein 
MSMEG_4287 
WP_003895683.1  
No data obtained 
 
Beta lacatamase penicillin-
binding protein  
MSMEG_5637 
WP_014876714.1 
MSMEI_0251 
 
 
Penicillin-binding protein B 
MSMEG_4233 
WP_011729661.1  
MSMEI_4133 
 
 
 
 
 
 
 
 
Reference species 
Best matches  Query sequence 
Query sequence Key 
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3.2. Ectopic expression of M. tuberculosis DD-CPases in M. smegmatis.  
As mentioned earlier, there is a multiplicity of DD-CPases in mycobacterial genomes and it is 
unclear if this is reflective of a redundancy in function or alternatively, the different homologues 
may retain specialist biological roles. The study by Bourai et al., (2012) demonstrated that 
heterologous expression of Rv2911 from M. tuberculosis in M. smegmatis leads to multiple 
defects including retarded growth, altered colony morphology, and aberrant sliding motility 
(Bourai et al., 2012). Considering this, in this study we aimed to characterize the physiological 
function of the different M. tuberculosis LMW PBPs, through ectopic expression in M. 
smegmatis. We recognize that heterologous expression has various limitations but hypothesized 
that a side-by-side assessment of the three homologues in the same heterologous host would 
provide some insight into specialist versus redundant function. For this, we constructed a set of 
recombinant M. smegmatis strains expressing Rv2911, Rv3330 and Rv3627c from the Psmyctet 
promoter which is classified as the strongest promoter in mycobacteria for gene regulation studies 
(Ehrt et al., 2005). Based on this, we expect that expression from the Psymctet promoter results in 
high abundance of M. tuberculosis DD-CPases in M. smegmatis. 
3.2.1. Generation and genotyping of heterologous M. smegmatis strains ectopically 
expressing M. tuberculosis DD-CPases    
The episomal pSE100 vector, carrying Rv2911, Rv3330 and Rv3627c was constructed as detailed 
in section 2.8.6. The resulting constructs (pSE2911, pSE3330 and pSE3627c) were propagated in 
E. coli DH5α and plasmid DNA was extracted as described in 2.4.2. The constructs were verified 
by restriction profiling and sequencing.  The restriction maps are shown in Appendix (Appendix 
D). The mc
2
155 strain was transformed by electroporation as described in section 2.11.2 with 
these constructs to generate the mc
2
(pSE2911), mc
2
(pSE3330) and mc
2
(pSE3627c) strains. A 
negative control strain, mc
2
(pSE100), carrying the empty vector was also generated. A single 
colony of each strain was picked and DNA extracted as detailed in section 2.3.2 for PCR 
confirmation using gene specific primers listed in the Appendix (Appendix B), Figure 3.2.1.  
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hygR 
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pSE100 F Rv2911_UTG_R 
 
 
Rv3330_UTG+pSE100 
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2000 
3000 
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5000 
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Rv3330_UTG 
1218 bps  
pSE100 R 
ori myc 
hygR 
ColE1 
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pSE100 F 
 
B  
 
Figure 3.2.1. PCR confirmation of presence of M. tuberculosis DD-CPases in M. smegmatis. (A) 
Primer binding sites for PCR confirmation of  of M. tuberculosis DD-CPases cloned into pSE100. 
The primer binding sites are indicated by the green marker/arrows. Primer pairs 
(Rv2911_UTG_F+Rv2911_UTG_R), (Rv3330_UTG_F+Rv3330_UTG_R) and 
(Rv3627c_UTG_F+Rv3627c_UTG_F) were used for PCR confirmation of Rv2911, Rv3330 and 
Rv3627c respectively. (B) PCR confirmation of Rv2911 (I) and Rv3627c (II) with annealing 
temperature at 70
0
C and 72
0
C respectively. Lane 1= Marker IV, Lane 2= narB (Positive control), 
Lane 3= No template control, Lane 4= No forward primer control, Lane 5= No reverse primer 
control, Lane 6= Rv2911, Lane 7= No template control, Lane 8= No forward primer control, Lane 
9= No reverse primer control, Lane 10= Rv3627c. (II) PCR confirmation of Rv3330 with 
annealing temperature of 70
0
C with primer pairs listed above. Lane 1= Marker IV, Lane 2= narB 
(Positive control), Lane 3= No template control, Lane 4= No forward primer control, Lane 5= No 
reverse primer control, Lane 6= Rv3330.  
I II 
 70 
 
3.2.2. Ectopic expression of M. tuberculosis DD-CPases in M. smegmatis significantly affects 
bacterial colony morphology 
Following the generation of the heterologous M. smegmatis strains as described in section 2.11.2, 
we observed some defects in colony morphology where the resulting colonies were smooth with a 
distinct mucoid surface surrounding the colony edge, figure 3.3.2. A similar defect was reported 
by Buorai et al., (2012) for the ectopic expression of Rv2911 and now we demonstrate that 
increased expression of any of the M. tuberculosis DD-CPases in M. smegmatis leads to similar 
defects.  
The smooth colonies which also lacked defined surface cording, a characteristic unique to 
mycobacterial species, were further analysed using the Zeiss STEMI-2000c dissecting 
microscope. At high microscopic resolution, we determined that the strains were able to initiate 
cording, as demonstrated by the presence of short surface indentations that did not mature into the 
full serpentine cords displayed by the wild type mc
2
155 strain, figure 3.2.2. The short cords and 
surface indentations were exacerbated for the mc
2
(pSE2911) and mc
2
(pSE3330) strain, figure 
3.2.2.  In addition, the heterologous strains displayed an abnormal colony edge, distinct from that 
observed for the mc
2
155 and mc
2
(pSE100) control strains,    
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Figure 3.2.2. Colony morphology of the recombinant M. smegmatis strains ectopically expressing 
M. tuberculosis DD-CPases. The strains were grown in liquid culture to log phase (OD600 0.5-0.9) 
and 100 µl was spotted on 7H10 agar plates. Images were obtained using the Zeiss STEMI-2000c 
dissecting microscope after a 3-day incubation period at 37
0
C.  The red arrows indicate smooth 
colonies with a mucoid surface edge. The yellow arrows illustrate wild type colony cording 
distinguished by clearly defined serpentine cords. The green arrows show short cords 
uncharacteristic of normal mycobacterial colony cording. The purple arrows point to the aberrant 
colony edge and the blues arrows indicate surface indentations.  
 
3.2.3. Ectopic expression of M. tuberculosis DD-CPases affects bacterial sliding on semi-solid 
agar  
Previous studies have demonstrated that the formation of smooth colonies in mycobacterial 
species, as observed for our heterologous M. smegmatis strains, is related to modifications in cell 
wall components such as glycopeptidolipids (GPLs). In particular, an increase in the abundance of 
cell wall GPLs (Moya-Hoyos et al., 2015) or acetylation (Recht and kolter. 2001) directly 
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influence bacterial sliding on semi-solid media by considerably altering the surface 
hydrophobicity of cells. As a result, the surface of cells becomes less hydrophobic allowing for 
migration from the point of inoculation on semi-solid media. This type of motility is hypothesized 
to play a pivotal role in surface colonization, potentially leading to disease establishment and 
dissemination during mycobacterial infection (Recht et al., 200; Martìnez et al., 2001) 
Considering the colony forming defects noted above, we decided to assess sliding motility of the 
heterologous M. smegmatis strains on 7H9 media, with 0.3% agar or agarose as described in 
section 2.16.3. A freshly streaked colony of each respective heterologous strain was placed at the 
center of an agar or agarose solidified 7H9 plate and sliding was monitored as shown in figure 
3.2.3 A and B. As an alternative, the strains were also stab-inoculated, figure 3.2.3 C.   
In all cases, data revealed that ectopic expression of M. tuberculosis DD-CPases in M. smegmatis 
significantly influences bacterial sliding on semi-solid agar, where motility was greatly enhanced 
on 7H9 media solidified with agar as shown in both figure 3.2.3 A and C. In addition, stab 
inoculation resulted in increased sliding, with strains reaching the edge of plates after 3 days of 
incubation, when compared to the wild type and empty vector control strain. The sliding of the 
heterologous strains on agarose solidified media did not extend over to large surface areas as 
observed on agar solidified media. This is most likely due to high concentrations of agarose (0.2% 
or above), which results in media that is rigid, thus preventing bacterial translocation over a large 
surface (Martìnez et al., 2001).  
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Figure 3.2.3. Sliding motility of the heterologous M. smegmatis strains on semi-solid media. 
Liquid 7H9 media was solidified with agar or agarose to a final concentration of 0.3%. A 3-day 
old freshly streaked colony of the heterologous stain was surface inoculated on (A) agar or (B) 
agarose solidified 7H9. Additionally, agar solidified 7H9 was stab inoculated with 10 µl liquid 
culture grown to log-phase (C).  
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3.2.4. Ectopic expression of M. tuberculosis DD-CPases in M. smegmatis results in delayed 
and aberrant biofilm formation 
The observed defects in colony morphology and sliding on semi-solid agar were suggestive of 
alterations in cell surface properties for the heterologous strains. This prompted us to further 
assess whether cell-cell interaction/communication including arrangement in an organized 
bacterial community, is retained upon ectopic expression of M. tuberculosis DD-CPases in M. 
smegmatis. Biofilms represent one of the best-studied models of cellular communities and we 
turned our attention to using this system to assess the behavior of our heterologous strains. A 
series of studies have demonstrated that both M. tuberculosis and M. smegmatis are capable of 
forming biofilms on both polyvinyl chloride and the air-media interface (Ojha et al., 2005; Ojha 
and Hatfull, 2007; Ojha et al., 2012). The air-media interface protocol to assess biofilm formation 
of the heterologous M. smegmatis strains. Biofilms were prepared in 6-well microtitre plates using 
Sauton’s minimal media as described in section 2.16.2. The plates were sealed with biohazard 
tape and incubated at 37
0
C in a standing incubator. The plates were viewed at 7 and 14 days 
respectively using the Zeiss STEMI-2000c dissecting microscope.  
At day 7, the mc
2
155 and mc
2
(pSE100) control strains formed mature biofilms, figure 3.2.4. The 
recombinant strains showed no indication of biofilm formation at this point and to further confirm 
whether these strains were competent for biofilm formation, the cultures were incubated under the 
same conditions for a further 7 days. After 14 days of incubation, mature biofilms were observed 
for the heterologous M. smegmatis strains. However, when viewed at high resolution with the 
Zeiss STEMI-2000c dissecting microscope, the biofilms were unevenly textured with severe 
surface nodules when compared to the mc
2
155 and mc
2
(pSE100) control strains. The data 
demonstrated that ectopic expression of M. tuberculosis DD-CPases in M. smegmatis significantly 
delays the efficiency at which cells switch from planktonic growth to a spontaneously self-
assembled community in the form of biofilms. In addition, the data demonstrated that ectopic 
expression of M. tuberculosis DD-CPases in M. smegmatis significantly affects biofilm 
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maturation, with the heterologous strains unable to form robust and mature biofilms when 
compared to the mc
2
155 and mc
2
(pSE100) control strains.  
 
  
 
 
 
 
Figure 3.2.4. Biofilm formation of the heterologous M. smegmatis strains ectopically expressing M. 
tuberculosis DD-CPases. The heterologous strains displayed delayed biofilm formation, with mature biofilms 
forming after a 14 day incubation period at 37
0
C. The resulting biofilms were unevenly textured with severe 
nodules.  
3.2.5. Ectopic expression of M. tuberculosis DD-CPases in M. smegmatis results in retarded 
growth in axenic culture 
To further understand the physiological role of the M. tuberculosis DD-CPases, a growth curve 
was conducted to evaluate the effect of ectopic expression of these proteins on growth rates of 
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heterologous M. smegmatis. Growth curve cultures were started as detailed in section 2.16.6. The 
heterologous strains displayed retarded growth at the onset of the log-phase, an effect that was 
lost during later stages of growth where these strains displayed similar levels of growth and 
biomass as those obtained for mc
2
155 and mc
2
(pSE100) strains, figure 3.2.5. Clumping of 
cultures was observed after 18 hours of growth and to circumvent this, cultures were gently 
swirled to disengage clumps before measuring the OD600 and plating for CFU/ml.  
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Figure 3.2.5. Growth curve analysis of the heterologous M. smegmatis strains. Growth was 
monitored by measuring the OD600 (A) and plating for CFU/ml (B) at 3-hour intervals. The growth 
curve was started at OD600 = 0.1 in liquid 7H9 media. (***, P<0.0001). 
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3.2.6. Ectopic expression of Rv2911 and Rv3627c significantly alters mycobacterial cell 
length and mechanisms of division. 
We next decided to study cell wall morphology using SEM to assess the impact of ectopic 
expression of M. tuberculosis DD-CPases in M. smegmatis. Cells were harvested at 3, 12 and 24 
hours representing the lag, log and stationary phases of growth. The OD600 of each strain was 
measured before harvesting cells to confirm that the cultures had reached the growth phase in 
question. Cells were prepared for SEM as detailed in section 2.16.5 and imaged using the high 
resolution FEI Nova NanoSEM 230 scanning electron microscope.  
Ectopic expression of Rv2911and Rv3627c resulted in reduced bacterial cell size, figure 3.2.6. To 
further confirm that cell size was greatly reduced in the mc
2
(pSE2911) and mc
2
(pS3627c) strains, 
the distribution of cell lengths for the heterologous strains was measured and expressed as 
percentage of the total population. The control strains and the mc
2
(pSE3330) strain have a majority 
of cells with a size range of between 4-6 µm. We noted a shift in the distribution of cell lengths in 
the majority of cells towards a cell size ranging <2 µm for the mc
2
(pSE2911) and mc
2
(pSE3627c) 
strains, during all stages of growth, Figure 3.2.7. This suggested that ectopic expression of these 
two DD-CPases caused dysregulation of cell elongation or division process.  
In addition to reduced cell length, the mc
2
(pSE2911) and mc
2
(pSE3627c) strains lacked the 
protruding peptidoglycan noted with proper septum formation for all cells undergoing division, 
seen in the enlarged inserts, figure 3.2.6. Furthermore, the septum of all cells undergoing division 
for these strains appears to invaginate as cells divide. This feature contrasts with that observed for 
the control and mc
2
(pSE3330) strains. The mc
2
(pSE3330) and mc
2
(pSE3627c) strains had cells 
with holes following ectopic expression of Rv3330 and Rv3627c respectively, figure 3.2.6.  
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Figure 3.2.6.  Cell length alteration and division defects displayed by the heterologous M. smegmatis strains as a 
result of ectopic expression of M. tuberculosis DD-CPases. The strains were cultured in liquid 7H9 (starting OD600 
= 0.05) and sampled at 3, 12 and 24 hours representing the lag, log and stationary phases of growth for SEM. The 
green parenthesis delineates the size of a single cell. The enlarged insert in red demonstrates the division site. The 
enlarged inserts in yellow indicate holes observed for the mc
2
(pSE3330) and mc
2
(pSE3627c). Scale bar= 5 µm 
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Figure 3.2.7. Cell length distribution of the heterologous M. smegmatis strains. Graph A, B and C 
represent cell length distribution of the heterologous strains at lag, log and stationary phases of 
growth respectively. The mc
2
155, mc
2
(pSE100) and mc
2
(pSE3330) strains displayed cell length 
distribution of between 4-6 µM. A shift to the left in cell length, with cell size <2 µM was 
observed for the mc
2
(pSE2911) and mc
2
(pSE3627c) strains. (n=100 ; ****, P<0.00001). 
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3.2.7. Ectopic expression of Rv3330 in M. smegmatis significantly affects cellular 
morphology 
The mc
2
(pSE3330) strain displayed robust morphological defects as revealed by SEM, that were 
not noted in the other strains.  The defects include the formation of cells with bulges, division 
scars, chaining of cells, kinking and branching/lateral growth, figure 3.2.8. The phenotypes were 
quantified and expressed as a percentage of the total population for cells in lag, log and stationary 
phases of growth. An increase in the number of cells showing abnormal cellular morphology was 
observed for the mc
2
(pSE3330) strain, figure 3.2.9. Another important observation is the lateral 
branching/growth of cells, exclusively observed for the mc
2
(pSE3330) strain, further 
substantiating that ectopic expression of Rv3330 in M. smegmatis  affects normal cellular 
morphology. 
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Figure 3.2.8. Abnormal cell wall morphology displayed by the mc
2
(pSE3330) strain. The insert in each 
image represent the enlarged cell morphology defect. The morphological defects include bulging of cells, 
division scars, chaining, kinking and lateral branching/growth of cells. Scale bar= 5 µm 
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Figure 3.2.9. Quantification of abnormal cellular morphology resulting from ectopic of Rv3330 
in M. smegmatis. Graph A, B and C represents the quantified phenotypes for each population of 
cells harvested at lag, log and stationary phases of growth respectively. The data shows a 
significant increase in cells that form chains, bulges and division scars for the mc
2
(pSE3330) 
strain relative to the mc
2
155 and mc
2
(pSE100) control strains. (n= 100; *, P<0.01; **, P<0.001; 
***; P<0.0001, ****;P<0.0001) 
 
3.2.8. Ectopic expression of M. tuberculosis DD-CPases disrupts normal cell wall architecture 
in M. smegmatis 
Examination of the cell surface by SEM revealed distinct cell morphology defects for the 
heterologous strains. To follow up on the effect of ectopic expression of M. tuberculosis DD-
CPases on cell morphology, TEM was conducted on the recombinant strains. The strains were 
cultured as previously described and sampled at lag, log and stationary phases of growth. The 
samples were prepared for TEM as detailed in sections 2.16.6 and imaged with the Tecnai F20 
Transmission Electron Microscope. TEM revealed two distinct cell wall defects for the 
heterologous strains: (I) the thickness of the wall was greatly increased and (II) the cell envelope 
displayed partial detachment from the cytoplasm, figure 3.2.10. To further demonstrate that the 
observed cell wall defects were significant, we quantified the total number of cells with abnormal 
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cell wall architecture and expressed as a percentage of the entire population, figure 3.2.11. The 
data revealed a significant increase of the abnormal cell wall phenotype for the mc
2
(pSE2911) 
strain at 3 and 9 hours. The abnormal cell wall architecture for the mc
2
(pSE3330) strain was only 
observed at log phase with abnormal cell wall defects observed at all growth phases for the 
mc
2
(pSE2911) and mc
2
(pSE3627c) strains. 
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Figure 3.2.10. Transmission electron micrographs of the heterologus M. smegmatis strains ectopically 
expressing M. tuberculosis DD-CPases at lag, log and exponential phases of growth. The inserts show an 
enlarged section of cells displaying abnormal cell wall architecture. The data demonstrated that ectopic 
expression of M. tuberculosis DD-CPases interferes with normal cell wall formation, resulting in cells 
with uneven cell wall architecture that appears to partially detach from the cytoplasm. Scale bar= 0.2 µm. 
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Figure 3.2.11. Quantification of cells displaying aberrant cell wall architecture resulting from 
increased expression of M. tuberculosis DD-CPases in M. smegmatis as revealed by TEM. The 
heterologous strain displayed abnormal cell wall characterized by increased thickness and partial 
detachment of the cell envelope from the cytoplasm. The frequency of cells displaying the cell 
wall defects increased for the mc
2
(pSE2911) and mc
2
(pSE3627c) at log phase with the  
mc
2
(pSE3330) strain displaying cell wall defects at log and stationary phases of growth. (n= 100) 
 
3.3. Ectopic expression of M. tuberculosis DD-CPase homologues in wild type H37RvS strain 
Data obtained for the heterologous M. smegmatis strains thus far strongly implicated M. 
tuberculosis DD-CPases in maintaining bacterial colony morphology, surface structure and sliding 
propensity, biofilm formation/maturation, growth in broth culture and normal cell length/division. 
We recognize that heterologous expression in M. smegmatis is a suitable system for 
characterization of the respective M. tuberculosis DD-CPase homologues, but there are various 
limitations of this system. The most important being that the biology of cell division may be 
different between M. smegmatis and M. tuberculosis. Considering this, we hypothesized that a 
side-by-side assessment of the three homologues in the native host would provide additional 
insight into the biological role of these proteins. In this component of the study, we aimed to 
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characterize the physiological function of M. tuberculosis DD-CPase homologues (previously 
expressed in M. smegmatis) through ectopic expression in wild type M. tuberculosis H37RvS. 
3.3.1. Construction and genotypic analysis of H37RvS strains that ectopically express 
individual DD-CPase-encoding genes 
The constructs carrying the untagged  M. tuberculosis DD-CPases previously used for generation 
of the heterologous M. smegmatis strains as reported in section 3.2 were introduced into the wild 
type M. tuberculosis H37RvS strain by electroporation as described in section 2.12.2 to generate 
the H37RvS(pSE2911), H37RvS(pSE3330), H37RvS(pSE3627c) recombinant strains. The 
H37RvS(pSE100) control strain, that carried the empty vector, was also generated. In each case, a 
single transformant was selected and DNA extracted for PCR confirmation of whether the 
selected strain carried the correct gene as described in section 2.3.2. The PCR confirmation 
primers used for confirmation of the heterologous M. smegmatis strains were employed for 
confirmation of the recombinant H37RvS strains. PCR analysis of each strain confirmed that they 
carried the expected M. tuberculosis DD-CPase, figure 3.1.3. 
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Figure 3.3.1. PCR confirmation of recombinant H37RvS strains carrying the M. tuberculosis DD-
CPases ectopically expressed in H37RvS. (A) Primer binding sites for PCR confirmation. The 
primer binding sites are indicated by the green marker/arrows. Primer pairs 
(Rv2911_UTG_F+Rv2911_UTG_R), (Rv3330_UTG_F+Rv3330_UTG_R) and 
(Rv3627c_UTG_F+Rv3627c_UTG_F) were used for PCR confirmation of Rv2911, Rv3330 and 
Rv3627c, respectively. (B) PCR confirmation of Rv3627c, Rv3330 and respectively. Lane 1= 
Marker III, Lane 2= narB (Positive control), Lane 3= No template control, Lane 4= No forward 
primer control, Lane 5= No reverse primer control, Lane 6= Rv3627c, Lane 7= No template 
control, Lane 8= No forward primer control, Lane 9= No reverse primer control, Lane 10= 
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Rv3330, Lane 11= No template control, Lane 12= No forward primer control, Lane 13= No 
reverse primer control, Lane 14= Rv2911.  
3.3.2 Ectopic expression of Rv3627c in H37RvS significantly affects bacterial cording 
The heterologous M. smegmatis strains displayed robust colony morphology and cording defects 
on solid 7H10 media when viewed at high microscopic resolution. To determine whether these 
are involved in maintaining normal colony morphology in H37RvS, single isolated colonies from 
the respective H37RvS recombinant strains were analysed using the Zeiss STEMI-2000c 
dissecting microscope as described in section 2.16.1. The recombinant H37RvS strains displayed 
no gross colony defects on plates as previously observed for the heterologous M. smegmatis 
strains and were characterized by surface cording comparable to wild type H37RvS colonies, 
figure 3.3.2. This suggested that the M. tuberculosis DD-CPase homologues are not involved in 
maintaining normal bacterial colony morphology in the H37RvS strain. To further confirm this, 
the resulting colonies of the recombinant strains were analysed for cording defects with the Zeiss 
STEMI-2000c dissecting microscope as described in section 2.16.1. At high microscopic 
resolution, we observed that the H37RvS(pSE2911) and H37RvS(pSE3330) recombinant strains 
were able to initiate cord formation which developed into the full serpentine cords comparable to 
those observed for the wild type H37RvS, figure 3.3.2. The H37RvS(pSE3627c) strain was also 
able to initiate cord formation but was unable to complete this process as demonstrated by the 
presence of short cords, which were not able to mature into the full serpentine cords as observed 
for the other strains, figure 3.3.2. This strain also displayed an abnormal colony edge, 
predominantly characterized by severe surface extensions with no observable serpentine cording. 
The data strongly demonstrated that Rv3627c is solely involved in maintaining normal bacterial 
cording in the H37RvS strain, with the remaining homologues displaying no observable role in this 
regard.    
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Figure 3.3.2. Colony morphology of the recombinant H37RvS strains ectopically expressing M. tuberculosis 
DD-CPases. The strains were cultured to log phase (OD600= 0.5-0.9) and plated on Middlebrook 7H11 agar to 
obtain single isolated colonies which were viewed at high microscopic resolution for cording defects. The 
blue arrows illustrate wild type colony cording distinguished by clearly defined serpentine cords. The 
H37RvS(pSE3627c) strain displayed short cords with surface extension that displayed no observable cording 
as shown by the red and purple arrows. 
 
3.3.3. Ectopic expression of Rv3627c in H37RvS significantly delays biofilm formation and 
maturation  
As mentioned earlier, colony defects are suggestive of alterations in cell surface properties that 
abolish cell-cell interaction/communication. We next sought to further study this by assessing the 
capacity of the H37RvS(pSE3627c) strain, which displayed colony morphology defects, to initiate 
and form mature biofilms. For comparison, we tested all the other strains, using the adopted  air-
media interface protocol as described in section 2.6.2. M. tuberculosis is a slow growing organism 
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and the formation of mature biofilms is different from M. smegmatis, requiring at least 5-weeks 
incubation at 37
0
C (Ojha et al., 2005., Ojha et al., 2008, Ojha et al., 2010 and Kulka et al., 2012). 
Based on this, biofilms were prepared in 6-well microtitre plates in minimal Sauton’s media and 
sealed with biohazard tape for 6 weeks.  
Following the 6 week incubation period, biofilm formation was assessed using the Zeiss STEMI-
2000c dissecting microscope as described in section 2.16.2. Mature biofilms were observed for 
the H37RvS and H37RvS(pSE100) control strains after the 6-weeks of incubation. The 
recombinant H37RvS strains that ectopically expressed DD-CPases displayed indications of 
initiating biofilm formation but at this point,  it was not conclusive whether these strains were 
competent to form mature biofilms, as previously reported for the heterologous M. smegmatis 
strains. To address this, it was decided to assess biofilm formation of the recombinant H37RvS 
strains at 4, 6 and 8 weeks after incubation, as this might provide more insight into the biofilm 
forming capacity of these strains.  
Following the 4-week incubation period, the recombinant H37RvS strains displayed little  
initiation of biofilm formation when compared to the wild type H37RvS and H37RvS(pSE100) 
control strains, figure 3.3.3. Following the 6-week incubation period, the control strains formed 
fully mature biofilms as previously observed. The H37RvS(pSE2911) and H37RvS(pSE3330) 
strains displayed robust biofilm initiation after six weeks compared to that observed after 4-
weeks. The H37Rv(pSE3627c) strain displayed poor biofilm initiation, accompanied by scattered 
biofilm growth after 6-weeks of incubation, figure 3.3.3.   
Based on the observed biofilm initiation phenotype displayed by the recombinant H37RvS strains, 
it was hypothesized that these strains are competent for biofilm formation but require extended 
incubation. To address this, the strains were incubated for an additional 2 weeks. Following the 8 
week incubation period, mature biofilms, comparable to wild type H37RvS and H37RvS(pSE100) 
control strains, were observed for the H37RvS(pSE2911) and H37RvS(pSE3330) strains. The 
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H37RvS(pSE3627c) at this point displayed robust biofilm initiation accompanied by slight biofilm 
maturation, figure 3.3.3.  
The series of data obtained, from initiation of biofilm formation to maturation demonstrated that 
adherence is a prerequisite for biofilm growth and maturation as observed for the recombinant 
strains, which firstly displayed a gradual increase in the robustness of  biofilm initiation then 
followed by biofilm maturation. The data demonstrated that in M. tuberculosis, colony 
morphology (or lack thereof) is not predicative of biofilm forming capacity. This is based on the 
observation for the recombinant H37RvS strains, with the H37RvS(pSE2911) and 
H37RvS(pSE3330) strains, which displayed no colony morphology defects but yielding delayed 
biofilm formation and maturation. Furthermore, the data point to a differential role for the 
respective DD-CPases in maintaining normal biofilm formation and maturation, with Rv3627c 
playing an important role in governing the rate at which biofilms form and mature.  
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Figure 3.3.3. Biofilm formation of the recombinant H37RvS strains ectopically expressing M. tuberculosis 
DD-CPase homologues. The H37RvS(pSE2911) and H37RvS(pSE3330) strains displayed delayed biofilm 
formation at week 4 and 6, followed by the formation of fully mature biofilms after 8 weeks of incubation 
at 37
0
C. The H37RvS(pSE3627c) strain also displayed a similar delay in the biofilm formation but failed to 
form mature biofilms following  the 8 week incubation period.  
 
3.3.4. The H37RvS recombinant strains ectopically expressing the M. tuberculosis DD-CPases 
displayed no growth retardation in liquid 7H9 media   
To further understand the physiological role of DD-CPases in bacterial proliferation, growth of the 
recombinant H37RvS strains was assayed in Middlebrook 7H9 media by monitoring the optical 
density of cultures at 600 nm (OD600) and plating for CFU/ml as described in section 2.16.4. The 
growth assay for the recombinant strains was started at OD600 = 0.05 and monitored on a daily 
basis. The recombinant H37RvS strains displayed growth rates comparable to the H37RvS and 
H37RvS(pSE100) control strains, figure 3.3.4 A. The data suggested that ectopic expression of the 
respective M. tuberculosis DD-CPase homologues does not alter growth rates in H37RvS, in 
contrast to what was observed for the heterologous M. smegmatis strains. To validate this, the 
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CFU/ml for each strain was also plotted and compared to that of the H37RvS and 
H37RvS(pSE100) control strains, figure 3.3.4 B. The data confirmed that growth of the 
recombinant H37RvS strains was comparable to that of the H37RvS and H37RvS(pSE100) controls, 
with the recombinant strains displaying similar biomass at each time point.  
A 
 
B 
 
Figure 3.3.4. Growth of the recombinant H37RvS strains in Middlebrook 7H9 media. (A) OD600 
and (B) CFU/ml of the recombinant H37RvS strains compared to the H37RvS and 
H37RvS(pSE100) control strains. The recombinant strains displayed growth rates comparable to 
the H37RvS and H37RvS(pSE100) control strains, suggesting that the respective M. tuberculosis 
DD-CPase homologues  are not involved in regulating growth in M. tuberculosis. 
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3.3.5. Recombinant H37RvS strains ectopically expressing M. tuberculosis DD-CPases 
displayed an increase in bacterial cell length as revealed by scanning electron microscopy 
(SEM)  
To assess the impact of ectopic expression of M. tuberculosis DD-CPase homologues on cell 
surface structure of the recombinant H37RvS strains, SEM images were obtained for these strains 
as described in section 2.16.5. Briefly, cells were harvested at day 3, 7 and 10 representing the 
lag, log and stationary phases of growth. The OD600 of each strain was measured before 
harvesting cells to confirm that the cultures had reached the growth phase in question. Cells were 
prepared for SEM and imaged using the high resolution FEI Nova NanoSEM 230 scanning 
electron microscope as described in section 2.16.5. 
Ectopic expression of Rv2911 and Rv3627c in mc
2
155 reduced bacterial cell size as previosuly 
observed, pointing to a possible role for these proteins in maintaining cell length and/or rates of 
cellular elongation. Ectopic expression of these DD-CPases in H37RvS resulted in a mixed 
population of cells with varying cell length, displaying both nornal and increased cell size, figure 
3.3.5. To further substantiate that ectopic expression of DD-CPases results in an increase in the 
proportion of cells with increased cell length, cell size distribution of the recombinant strains  was 
measured and compared to that of the control strains, figure 3.3.6. The data demonstrated an 
increase in the population of cells with a 3.5-5.0 µm cell size range. The increase in the 
proportion of cells with longer cell length point to  a redundant role for the  M. tuberculosis DD-
CPases in maintaining normal bacterial cell length.  
The recombinant H37RvS strains displayed none of the cell surface morphology defects 
previously observed for the heterologous M. smegmatis strains. Surface extensions were observed 
on cells harvested at lag phase for the  H37RvS(pSE3330) strain as shown by the large insert in 
figure 3.3.5. These surface extensions,  which are present on and around the the majority of cells, 
appeared to be involved in cell-cell adhesion, with adjacent cells linked together by these surface 
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structures. In some cases, we observed breakage of the extensions linking the two separate cells, 
figure 3.3.5. To address the concern that the surface extensions could have arisen from the 
preperation procedure, we assessed SEM micrographs of the wild type and H37RvS(pSE100) 
control strains and found that they were absent from these strains. This suggested that the surface 
extensions arose directly from ectopic expression of Rv3330. 
This is further substantiated  by the observation that on SEM micrographs, this strain appeared as 
bacterial clusters for log phase cultures, further confirming that the observed surface extensions 
are not a result of the preparation procedure but are undoubtedly as a result of ectopic expression 
of Rv3330 in H37RvS. The physiological significance of the observed surface extensions as a 
result of ectopic expression of Rv3330, however, remains unclear and is beyond the scope of the 
current study.  
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Figure 3.3.5. Cell surface of the recombinant H37RvS strains at lag, log and staionary phases of growth as 
revealed by SEM. The green parenthesis deliniate a single cell of normal size with a1.5-3 µm cell size range. 
The yellow parenthesis deliniates cells with increased cell length with a cell size range of 3-4.5 µm observed 
for the recombinant strains. The enlarged insert demonstrates surface extensions/structures observed for 
H37RvS(pSE3330) strain at lag phase. Scale = 5 µm 
H37RvS 
H37RvS(pSE100) 
H37RvS(pSE2911) 
H37RvS(pSE3330) 
H37RvS(pSE3627c) 
Lag phase                
(Day 3)  
Log phase                
(Day 7)  
Stationary phase                
(Day 10)  
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Figure 3.3.6. Cell length distribution of the recombinant H37RvS strains. The graphs represent 
cell length distribution at lag (A), log (B) and stationary (C) phases of growth. M. tuberculosis 
strains ectopically expressing DD-CPases displayed an increase in the proportion of cells with a 3-
4.5 µm size range. In gragh B, the cell legnth of the H37RvS(pSE3330) is excluded because of 
clumping of cells which precluded measurement of cell length for single. (n=100; ***, P<0.001; 
****, P<0.00001) 
**** 
*** 
*** 
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3.3.6. Ectopic expression of M. tuberculosis DD-CPases in H37RvS does not affect normal 
bacterial cell wall architecture as revealed by transmission electron microscopy (TEM)  
Ectopic expression of M. tuberculosis DD-CPases in the heterologous M. smegmatis strains 
revealed a possible role for maintaining normal bacterial cell wall architecture. To examine these 
enzymes in the recombinant H37RvS strains, TEM was performed as detailed in section 2.16.6. 
Cells were harvested at lag, log and stationary phase for imaging with the Tecnai F20 
Transmission Electron Microscope.  
TEM requires large cultures volumes at each time point to obtain grids with sufficient cells for 
viewing. This is dependent on the growth phase, with lag phase cultures requiring at least 30 ml 
culture volume compared to stationary phase cultures. Due to strict operating conditions in the 
BSLIII laboratory, the culture volume was greatly reduced to 5 ml at each time point. This was a 
major disadvantage as empty grids for all strains were obtained for cultures harvested at lag and 
log phases of growth. A few images for each strain were obtained with stationary phase cultures 
and the micrographs demonstrated that ectopic expression of M. tuberculosis DD-CPase 
homologues does not affect cell wall morphology, figure 3.3.7. At this point, this conclusion is 
based on the micrographs obtained for the recombinant strains at stationary phase only, which 
may not appropriately represent the entire population.  
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Figure 3.3.7. Transmission electron micrographs of the recombinant H37RvS strains obtained for 
stationary phase cultures. (A) scanning electron micrographs at x5700 magnification (B) depicts 
the zoomed images shown in A for each strain. The red arrows point to the enlarge cell 
wall/envolepe of the respective strains. The data demonstrated that ectopic expression of the 
respective M. tuberculosis DD-CPase homologues in H37RvS does not affect bacterila cell wall 
architecture. Scale bar= 0.2 
A B 
H37RvS 
H37RvS(pSE100) 
H37RvS(pSE2911) 
H37RvS(pSE3330) 
H37RvS(pSE3627c) 
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3.4. M. tuberculosis rseGFP tagged DD-CPase derivatives displayed polar, mid-cell and 
quarter cell position localization when ectopically expressed in M. smegmatis 
Our data thus far strongly suggest that M. tuberculosis DD-CPases are involved in maintaining a 
variety of cellular processes. To understand where in the cell these proteins exert their effects, 
cellular localization of rseGFP C-terminally tagged DD-CPase derivatives were constructed by 3-
way cloning into pSE100 as described in section 2.8.6. The constructs were confirmed by 
restriction profiling and sequencing and introduced into mc
2
155 by electroporation to generate the 
mc
2
(pSE2911-rseGFP), mc
2
(pSE3330-rseGFP) and mc
2
(pSE3627c-rseGFP) strains. A single 
colony was picked and DNA extracted to confirm by PCR whether the selected strain express the 
correct protein fusion. The PCR confirmation primers are listed in the Appendix (Appendix B). 
Figure 3.4.1 shows the primer binding sites for PCR confirmation of the respective DD-CPase 
fusion proteins cloned into pSE100 for the selected strains and PCR confirmation of the 
respective DD-CPase fusion proteins.  
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Figure 3.4.1. PCR confirmation of rseGFP C-terminally tagged M. tuberculosis DD-CPase 
derivatives. (A) Primer binding sites for PCR confirmation of rseGFP C-terminally tagged M. 
tuberculosis DD-CPase derivatives cloned into pSE100. The primer binding sites are indicated by 
the green marker arrows. Primer pair (Rv2911_UTG_F+rseGFP_R), 
(Rv3627c_UTG_F+rseGFP_R) and (Rv3330_UTG_F+rseGFP_R) were used for PCR 
confirmation of Rv2911-rseGFP, Rv3330-rseGFP and Rv3627c-rseGFP. (B) PCR confirmation 
of rseGFP C-terminally tagged M. tuberculosis DD-CPase derivates. (I) PCR confirmation of 
Rv2911-rseGFP fusion protein with annealing temperature at 72
0
C. Lane 1= Marker IV, Lane 2= 
narB (Positive control), Lane 3= No template control, Lane 4= No forward primer control, Lane 
5= No reverse primer control, Lane 6= Rv2911-rseGFP protein fusion. (II) PCR confirmation of 
Rv3330-rseGFP and Rv3627c-rseGFP protein fusions with annealing temperature at 70
0
C and 
72
0
C respectively. Lane 1= Marker IV, Lane 2= narB (Positive control), Lane 3= No template 
control, Lane 4= No forward primer control, Lane 5= No reverse primer control, Lane 6: Rv3330-
rseGFP fusion, Lane 7= No template control, Lane 8= No forward primer control, Lane 9= No 
reverse primer control, Lane 10= Rv3627c-rseGFP. 
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The heterologous M. smegmatis strains ectopically expressing the fusion proteins were subjected 
to the same assays conducted for the heterologous M. smegmatis strains ectopically expressing the 
untagged DD-CPases as reported in section 3.2 to confirm that the rseGFP fluorescence tag is 
functional and does not interfere with the activity of the respective DD-CPases. The strains 
ectopically expressing the untagged and rseGFP tagged protein derivatives yielded similar results 
for the assays conducted (data not shown), confirming that the rseGFP fluorescent tag is 
functional and that its activity does not interfere with that of the respective DD-CPases.  
The heterologous M. smegmatis strains carrying the fusion proteins were cultured in 7H9 to log 
phase (OD600 = 0.5-0.9). Cells were heat fixed on cover slips after three times washes with PBS as 
detailed in section 2.17, heat fixed and mounted on slides with fluoromount for imaging with the 
Zeiss 100x, 1.46 numerical aperture objective mounted to an Axio Observer Z1 base.  The images 
obtained for cellular localization of the DD-CPase in the heterologous strains are shown in figure 
3.4.2.  
The M. tuberculosis DD-CPases displayed various patterns of localization, figure 3.4.2. To 
determine the most consistent pattern of localization for each fusion protein in each strain, we 
quantified distribution of the different localization patterns displayed by respective DD-CPase 
fusion proteins, Figure 3.4.3. A unique pattern of cellular localization for the M. tuberculosis DD-
CPases in the heterologous strains with foci observed at both poles, mid-cell and quarter cell 
position was determined to be the most consistent pattern of localization, figure 3.4.3. To our 
knowledge, the observed cellular localization for the M. tuberculosis DD-CPase fusion proteins in 
M. smegmatis, has not been reported for any of the known proteins involved in PG remodelling. 
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Figure 3.4.2. Cellular localization of C-terminally tagged rseGFP M. tuberculosis DD-CPase 
derivatives in M. smegmatis. The heterologous strains were cultured to log phase and heat fixed 
before mounting on slides with fluoromount for imaging. The panels marked (I), (II) and (III) 
show the images obtained through the DIC channel, fluorescence channel and a merge of both the 
DIC and fluorescence channel respectively. The panel marker (IV) shows an enlarged image 
obtained through the fluorescence channel 
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Figure 3.4.3. Quantification of cellular localization of rseGFP tagged M. tuberculosis DD-CPase 
fusion proteins ectopically expressed in mc
2
155. The image labeled (A) shows the different 
patterns of localization observed for the M. tuberculosis DD-CPase derivatives and (B) is a 
graphic representation of the distribution of cellular localization for the fusion proteins. The data     
revealed that the three proteins localize at both poles, mid-cell and quarter cell position. (n=100) 
 
4. Discussion  
As with any infectious agent, the successful nature of M. tuberculosis as a pathogen is primarily 
related to its inherent ability to grow and proliferate in the presence of both immune and drug 
assault. Consequently, a substantial understanding of the different processes that underpin growth 
and cell division in this organism is of utmost importance for the design of effective, target based 
novel anti-TB drugs. Bacterial growth and division is a sophisticated process, involving the 
coordinated expansion and cleavage of the different layers in the cell envelope, a process 
mediated by multiple enzymes. In this study, we focused our attention on the mycobacterial PG 
degrading DD-CPases, a group of enzymes implicated in maintaining normal growth and survival 
in other organisms (Nelson and Young, 2001). Disease progression and viability of M. 
tuberculosis, involves the maintenance of a structurally functional cell wall and the PG layer in 
this case is of particular importance as it anchors the MAs and AG to create the PG-AG-MAs 
A 
B 
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complex. As mentioned earlier, PG remodelling involves the activity of multiple enzymes, some 
of which interact with various proteins to fulfil their function. One of the aims of this study was to 
determine whether mycobacterial DD-CPases exert their effect as singular enzymes or through 
interaction with various proteins as observed for other PG remodelling enzymes. This research 
question was based on two important observations, which include: (I) In other organisms, 
experimental and crystallographic data point to an interaction between PBPs, to allow for PG 
remodelling during cellular growth or division (Kuzin et al., 1995; Sauvage et al., 2008; van der 
Ploeg et al., 2013, Hett et al., 2007, Hett et al., 2008) (II) available data on mycobacterial 
elongation and division, demonstrated that these two processes are  dynamic, directed by protein 
complexes requiring  the participation of PBPs (Mukherjee et al., 2009; Hett et al., 2010; Kieser 
and Rubin, 2014). Considering this, we sought to determine if mycobacterial DD-CPases, which 
are predicted to be important in maintaining normal mycobacterial growth and survival by 
regulation of the amount of PG cross-linking, are part of any of the identified cell wall 
remodelling complexes,  the divisome and/or elongasome.   
To further expand on the current knowledge and physiological function of mycobacterial DD-
CPases, we identified putative interacting partners for two M. smegmatis DD-CPases, 
MSMEG_2433 and MSMEG_6113, using the mPFC assay. These two proteins were chosen 
based on unpublished data from the CBTBR which suggested that the former was expressed in 
high transcript abundance and the latter was essential for growth (C. Ealand and B. Kana, 
unpublished). The assay revealed multiple putative interacting partners for these proteins 
demonstrating that they possibly exert their effect through multi-protein complexes, table 3.1.2 
and table 3.1.3. Whilst we identified numerous partners, in the discussion that follows, we focus 
on those that are either periplasmic/membrane bound and have been reported to be involved in PG 
remodelling, with predicted effects on cell elongation or division. 
 
 108 
 
4.1. Interaction between MSMEG_2433 and MSMEG_6113 with PBPs 
4.1.1. MSMEG_6113 and Beta lactamase penicillin-binding protein  
β-lactamases are a group of proteins with the ability to bind and hydrolyse β-lactam antibiotics 
such as penicillin and are the major contributing factor to β-lactam resistance (Bush et al., 1995). 
Deletion of BlaC and BlaS, the major β-lactamases in M. smegmatis and M. tuberculosis, 
abolished the intrinsic resistance of these strains to β-lactam antibiotics (Flores et al., 2005). This 
observation demonstrated an essential role of β-lactamases for cell survival and viability in 
mycobacteria. Putative interaction of MSMEG_6113 with a β-lactamase, points to an additional 
role for this DD-CPase in maintaining cell survival either through the modulation of β-lactamase 
activity or by modifying PG during β-lactam treatment.  
4.1.2. MSMEG_2433 and Penicillin binding protein transpeptidase domain protein (PbpA) 
PbpA is a class B PBP that plays a role in bacterial growth (Wei et al., 2003). In M. smegmatis, 
PbpA localizes at the septum with a significant role in cell division as demonstrated by cell 
division defects in the PbpA mutant (Dasgupta et al., 2006).  Genetic complementation of a PbpA 
M. smegmatis mutant with the M. tuberculosis counterpart reverses the cell growth and division 
defects (Dasgupta et al., 2006), suggesting a conserved physiological role for this protein in 
mediating cell division. Amino acid sequence comparison of PbpA from five mycobacterial 
species revealed that this protein is indeed highly conserved (Dasgupta et al., 2006). It has been 
demonstrated that the phosphorylation status of PbpA, by either protein kinase PknA or PknB 
regulates the activity of PbpA (Kang et al., 2005; Dasgupta et al., 2006; Kieser et al., 2015; Chaba 
et al., 2002).  
These protein kinases are in turn regulated by autophosphorylation or through phosphatase 
activity. In M. tuberculosis, PknB is regulated by a phosphatase, PstP (Boitel et al., 2003). It is 
unclear whether the same system prevails in M. smegmatis. Cellular localization data places PbpA 
at the septum and poles of dividing cells (Kieser et al., 2015). Considering that PbpA is involved 
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in synthesis of the PG polymer, the interaction between this protein and MSMEG_2433, suggests 
that the latter may be involved in regulating PG synthesis at the cell poles and septum.   
4.1.3. MSMEG_2433 and the bifunctional penicillin–binding protein A1/1B (PonA1) 
PonA1, encoded by MSMEG_6900 in M. smegmatis is a bi-functional class A PBP, with separate 
domains that harbour transglycosylation and transpeptidation activities, which are required for 
cross-linking of new PG units to the existing polymer in the periplasm (Machowski et al., 2014). 
PonA1 localizes at the poles and at the septum of actively growing cells (Hett et al., 2010). In 
mycobacteria, PonA1 is involved in the regulation of multiple cellular processes, with the 
transpeptidase domain being dispensable for growth and viability (Kieser et al., 2015). The     
PonA1-regulated processes include the maintenance of normal bacterial cell length and 
morphology and the establishment of new poles, both of which are required for virulence during 
the murine model of TB infection (Kiesser et al., 2015). As previously mentioned for PbpA, the 
activity of PonA1 is also subject to regulation by phosphorylation (Prisic et al., 2010; Kiesser et 
al., 2015), further signifying the role of protein kinases in regulating key cell division processes. 
The interaction of MSMEG_2433 with PonA1 suggests that PonA1 recruits MSMEG_2433 at the 
poles following establishment of the new pole. This also suggests that in addition to FtsH 
(predicted in this study to inhibit FtsZ (see section 4.2.1), PBPs may also be involved in the septal 
recruitment of MSMEG_2433 at the divsome.  
4.1.4. MSMEG_2433 and the penicillin-insensitive transglycosylase/penicillin-sensitive 
transpeptidase (PonA2) 
PonA2 is also a bifunctional class A PBP (Machowski et al., 2014). M. smegmatis and other soil 
mycobacteria encode an additional homologue of PonA2, annotated as PonA3 (Patru and Pavels, 
2010; Machowski et al., 2014). PonA2 in M. smegmatis is implicated in maintaining viability 
under nutrient starvation or during stationary phase growth (Keer et al., 2000; Patru and Pavels, 
2010). The mechanism leading to PonA2 adaptation to these conditions is unclear, with opposing 
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ideas proposed with respect to how PonA2 contributes to cell viability under stressful conditions 
(Goffin and Ghuysen, 2002; Mainard et al., 2000; Mainard et al., 2005). The study by Patru and 
Pavels, 2010 suggested that adaptation to stressful environment requires the maintenance of cell 
wall integrity facilitated by PonA2 (Patru and Pavels, 2010).  
Currently, it is unknown whether PonA2 is part of the divisome or elongasome complex in 
mycobacteria. The protein harbours a PASTA domain, previously identified in other PG 
associated proteins such as PbpA, which is proposed to direct proteins to the division site 
(Dasgupta et al., 2016). In addition to the PASTA domain, PonA2 also consists of a proline-rich 
region predicted to mediate protein interaction. Based on these two features we propose that 
PonA2 is first recruited to the division site of actively growing cells and following the correct 
placement at the septum by the PASTA domain, the proline-rich region recruits MSMEG_2433 
through protein interaction, facilitating proper septum cleavage. The septal localization of PonA2 
has been confirmed in a study demonstrating that PonA2 acts to modulate the synergistic 
association of RpfB and RipA (Hett and Rubin, 2010), both of which co-localize at the septum 
(Hett et al., 2007; Hett et al., 2008).  
4.1.5. MSMEG_6113 and Penicillin binding proteins B (PbpB) 
PbpB is a class B PBP and shares similar characteristics with PbpA. This protein is recruited to 
the septum of dividing M. smegmatis cells, mediating cell division as deletion of PbpB results in 
altered cell length (Dasgupta et al., 2006). The interaction of MSMEG_6113 with PbpB suggests 
a possible role in cell division.   
4.2. Interaction between MSMEG_2433 and MSMEG_6113 with other 
periplasmi/membrane bound proteins  
4.2.1. MSMEG_2433 and the ATP-dependent zinc metalloprotease FtsH 
FtsH is a membrane anchored ATP-dependent, zinc metalloprotease belonging to the AAA family 
of ATPases (Herman et al., 1995). It is conserved in prokaryotes but also found in chloroplasts 
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and mitochondria of eukaryotic species (Ito and Akiyama. 2015; Lindahl et al., 1996). In 
prokaryotes, it acts as a quality control protein (Fischer et al., 2002), assisting in protein folding 
and degradation, directly maintaining cell viability during bacterial development (Gottesman, 
1996). In B. subtilis, a GFP tagged FtsH fusion displayed mid-cell localization, a preferential site 
for FtsZ polymerization in actively growing cells (Wehrl et al., 2000). In addition, deletion of this 
gene in B. subtilis results in the formation of cellular filaments (Wehrl et al., 2000). This 
observation points to two possible roles for FtsH, either as a component of the divisome complex 
where it facilitates cleavage of the septum or as a direct inhibitor of FtsZ polymerization at 
inappropriate sites during cell growth. The latter is substantiated by demonstration that in E. coli, 
in vitro assays confirmed that FtsZ is subjected to degradation by FtsH (Anilkumar et al., 2001; 
Srinivasan et al., 2006; Srinivasan et al., 2008), suggesting that FtsH is a negative regulator of 
FtsZ. Genetic complementation of a E. coli FtsH mutant with M. tuberculosis FstH, further 
revealed that the latter is proteolytically active against the heat shock transcription factor σ32, 
phage λCII and the SecY proteins, which are the other substrates of FtsH (Srinivasan et al., 2006). 
Based on this observation, we predict that the mycobacterial FtsH might also be active against 
FtsZ, inhibiting its polymerization over replicating chromosomal DNA during cell growth and 
division. In C. crescentus, overproduction of FtsH resulted in increased tolerance to stress, with 
mutant strains showing reduced efficiency in differentiation of swarmer cells into stalk cells, 
accompanied by cell division defects (Fischer et al., 2002), further signifying the role of FtsH in 
maintaining normal cellular development, probably through regulation of FtsZ activity. The 
possible interaction of MSMEG_2433 with FtsH, most likely at the septum, suggests that 
MSMEG_2433 may be involved in the pathway(s) that mediate correct spatial and temporal 
placement of the septum.  
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4.2.3. MSMEG_2433 and UDP-diphospho-muramoylpentapeptide beta-N- 
acetylglucosaminyltransferase (MurG) 
The MurG glycosyltransferase catalyzes the final cytoplasmic step of PG biogenesis, mediating 
the transfer of GlcNAc from UDP-GlcNAc to lipid I (Mengin-Lecreulx et al., 1991, Tayler et al., 
2010). The product of this reaction, Lipid II, is translocated across the membrane for processing 
and incorporation into the existing PG polymer by PBPs. In E. coli, MurG displayed scattered 
localization over the entire length of the cell with a distinct preference for the mid-cell 
(Mohammadi et al., 2007). Further analysis of MurG localization revealed that this mid-cell 
localization of MurG was dependent on the formation of a mature divisome, and that lateral 
localization was dependent on the presence of MreCD (Mohammadi et al., 2007), required for 
shape maintenance in rod-shaped bacteria. The observed lateral and mature divisome dependent 
localization suggest a possible role for MurG in regulating lateral growth and PG synthesis at the 
septum. In mycobacteria, a recently identified FtsZ-interacting protein, SepF, also interacts with 
MurG (Gupta et al., 2015), implicating MurG in linking the two distinct processes, PG biogenesis 
and cell division. Our identification of possible interaction between MSMEG_2433 and MurG is 
indicative of further complexity in these and related processes.   
4.2.4. MSMEG_2433 and UDP-N-acetylenolpyruvoylglucosamine reductase (MurB) 
UDP-N-acetylenolpyruvoylglucosamine reductase is encoded by MurB. This protein is involved 
in the second cyplasmic step of PG biogenesis. Following MurA mediated production of 
UDPGlcNAcEP, MurB reduces the phosphoenolpyruvate to produe UDPMurNAc (Matsaou et 
al., 2003). Currently, there is no literature linking the activity of the MurB reductase to either cell 
division or elongation and its interaction with MSMEG_2433 requires further confirmation.  
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4.2.5. MSMEG_6113 and the cell division control protein Cdc48 
The Cdc48 cell division protein is relatively uncharacterized in prokaryotes, belonging to the 
ATPase family of proteins along with FtsH that acts as molecular chaperone and negative 
regulator of FtsZ. Thus, it is unclear whether this protein also affects cell division in a mechanism 
mediated by FtsH, or whether it is involved in regulating other cellular processes unrelated to 
FtsH. In Saccharomyces cerevisiae, this protein is required for spindle disassembly at the end of 
mitosis (Cao et al., 2003), suggestive of a cell-cycle regulatory role for Cdc48 in mycobacteria. 
4.3. Proposed model for biological role of MSMEG_2433 and MSMEG_6113  
Considering the above-mentioned protein interactions, and the cellular localization of the 
interacting partners we propose a model for the cellular localization and physiological role of 
MSMEG_2433 and MSMEG, figure 4.1.1.  
 
FtsZFtsH
Unbundled FtsZ filaments 
MurG
MurG
Cell division control protein Cdc48?
RipA RpfB
MurG
 
Figure 4.1.1. A proposed model for the function of MSMEG_2433 and MSMEG_6113. Shown 
are MSMEG_2433 and MSMEG_6113 and their putative interacting partners, with proposed 
roles, either in cell elongation or division. Based on protein interaction data, we predict that both 
MSMEG_2433 and MSMEG_6113 are present at the pole and at mid-cell, interacting with well-
known proteins involved in either cell elongation or division. Additionally, the model proposes 
that MSMEG_2433 is involved in the correct placement of FtsZ, through interaction with FtsH.  
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4.4. Ectopic expression of M. tuberculosis DD-CPase homologues 
4.4.1. M. tuberculosis DD-CPases and maintenance of normal colony morphology 
Colony morphology of infectious pathogenic bacteria influences virulence and disease 
progression (Simpson et al., 1987; Darzins and Fahr, 1956; Bernut et al., 2014). Therefore, an 
enhanced understanding of the different factors that contribute to changes in colony morphology 
is crucial for drug development (Kansal et al., 1998). In mycobacteria, the maintenance of normal 
colony morphology is dependent on multiple factors, including pcaA and lsr2 gene products 
(Glickman et al., 2000; Chen et al., 2006). Bourai et al., (2012) demonstrated a role for M. 
tuberculosis Rv2911-encoded DD-CPase in maintaining normal colony morphology when 
ectopically expressed in M. smegmatis.  In our study, we sought to build on these observations by 
carrying out a side-by-side assessment of functionality of all three DD-CPase encoding genes in 
M. tuberculosis. We appreciate that ectopic expression in a heterologous host has limitations 
which include: (I) differences in cell division between hosts (II) variation between hosts in the 
complement of interacting partners and (III) increased expression can lead to non-specific effects 
on cell division/morphology. However, we had chosen to ectopically express the three M. 
tuberculosis DD-CPases in the same vector backbone, using the same promoter (pmyctet) and 
consequently, we predicted that any differential effects that result from over-expression of these 
genes could provide an insight into biological roles and functional redundancy. We demonstrated 
that ectopic expression of the M. tuberculosis DD-CPase homologues affects colony morphology 
in both M. smegmatis and M. tuberculosis. The resulting colonies were smooth, surrounded by a 
mucous surface and lacked the fully matured bacterial cords observed for the mc
2
155 strain. 
These data suggested a redundant role of these proteins in maintaining normal colony morphology 
in M. smegmatis. However, further analysis through ectopic expression in H37RvS revealed that 
increased expression of Rv3627c significantly alters bacterial colony morphology, thus 
highlighting a role for Rv3627c in mediating the organization of individual cells into colonies on 
agar plates in M. tuberculosis.  
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4.4.2. M. tuberculosis DD-CPases and their role in bacterial motility  
Bacterial sliding on semi-solid media is a characteristic that is directly linked to alterations in cell 
surface properties in mycobacteria. The increase in cell wall GPLs or acetylation significantly 
affects bacterial sliding (Moya-Hoyos et al., 2015; Recht and kolter, 2001). Additionally, the 
phosphorylation activity of protein kinase (PknF) also alters sliding motility in M. tuberculosis 
(Gopalaswamy et al., 2008)   
Ectopic expression of M. tuberculosis DD-CPase homologues in M. smegmatis resulted in defects 
in surface sliding. Bourai et al., (2012) demonstrated a similar role for Rv2911 in regulating 
bacterial sliding using the heterologous approach that we employed for characterization of the M. 
tuberculosis DD-CPase homologues. Our data also implicates Rv3330 and Rv3627c in regulating 
bacterial sliding, suggestive of a role for DD-CPases in modulating either the GPL content in the 
mycobacterial cell wall or other aspects of PG biology that affect the bio-physical characteristics 
of the cell.  
4.4.3. M. tuberculosis Rv3627c and biofilm formation 
Biofilm formation in pathogenic bacteria is illustrative of a survival strategy to survive during 
periods of stress and antibiotic treatment. Multiple factors are implicated in maintaining normal 
biofilm formation in mycobacteria. This includes alterations in surface GPLs (Milena Maya-
Hoyos et al., 2015; Recht and kolter, 2001), the GroEL1 chaperone (Ojha et al., 2005), the 
phosphorylation activity of PknF (Gopalaswamy et al., 2007), the dependence on various metal 
ions (Ca
2+
, Mg
2+
 and Zn
2+
) (Carter et al., 2003; Ojha and Hatfull, 2007), free MAs (Ojha et al., 
2008), the biological activity of the Polyketide PksI protein (Pang et al., 2012) and  the Lsr2 
protein (Chen et al., 2006). Our study further implicates mycobacterial DD-CPases in maintaining 
normal biofilm formation based on the following observations: (I) ectopic expression of M. 
tuberculosis DD-CPase homologues in M. smegmatis significantly delayed biofilm formation and 
(II) further assessment of the role of these proteins in maintenance of biofilm formation in the 
recombinant M. tuberculosis H37RvS strain substantiated that they regulate the rate at which 
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biofilms form and mature. In our analysis, the H37RvS(pSE3627c) strain displayed notably 
delayed kinetics in biofilm formation, suggesting a hierarchy in the role of DD-CPases in biofilm 
formation, with Rv3627c ranking the highest.  
4.4.4. M. tuberculosis DD-CPases and their role in bacterial growth  
The capacity of a pathogen to grow is critical for survival and disease progression. In this study, 
we assayed growth of heterologous M. smegmatis strains ectopically expressing M. tuberculosis  
DD-CPases in nutrient rich Middlebrook 7H9 media and observed notable defects. The 
heterologous strains displayed growth retardation, which was exacerbated at log phase, suggesting 
that M. tuberculosis DD-CPase homologues play a prominent role when bacteria are replicating 
rapidly. However, similar assessment of the impact of over-expression of DD-CPases in M. 
tuberculosis yielded contrary results where ectopic expression resulted in no changes in growth 
rates. Consequently, the role of the M. tuberculosis DD-CPases in growth requires further study 
and in this regard, it is noteworthy that Rv3627c has been annotated as essential for growth in 
vitro (Griffin et al., 2011).  
4.4.5. M. tuberculosis Rv2911 and Rv3627c and their role in maintaining normal bacterial 
cell length and mechanisms of cells division  
Using SEM, we identified a role for Rv2911 and Rv3627c in regulating bacterial cell length in M. 
smegmatis. Ectopic expression of these two DD-CPases in wild type M. tuberculosis H37RvS, also 
resulted in an increase in cell size. Combinatorial deletion of multiple E. coli PG hydrolases 
significantly affects bacterial cell size, with cells losing the natural rod-shape and adopting an 
almost spherical shape (Heidrich et al., 2002). This observation, together with our data implicates 
PG hydrolases such as DD-CPases in regulating bacterial cell length.  
However, we noted differential effects on cell length in M. smegmatis and M. tuberculosis where 
in the former we observed an increase in the populations of cells with reduced cell size for 
mc
2
(pSE2911) and mc
2
(pSE3627c) strains [and with mc
2
(pSE3330) to a lesser extent]. However, 
in M. tuberculosis, we observed growth-stage specific changes in cell length, table 4.1.1. These 
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data suggests that the two mycobacterial strains used in this study compensate differentially in 
response to increased expression of DD-CPases and also point to important differences in the 
biological function of PG remodelling enzymes between these two strains.  
 
Table 4.1.1. Cell length displayed by the heterologous M. smegmatis and recombinant M. 
tuberculosis H37RvS strains at different phases. The data illustrates that the two strains, mc
2
155 
and H37RvS, compensate differentially following ectopic expression of the M. tuberculosis DD-
CPases. (*, not done). 
 
Recombinant 
strain 
 
Lag Phase 
 
Log Phase Stationary 
Phase 
M. smegmatis     
mc
2
(pSE2911) Reduction in 
cell length 
Reduction in 
cell length 
Reduction in 
cell length 
mc
2
(pSE3330c) No change in 
cell length 
Reduction in 
cell length 
Reduction in 
cell length 
mc
2
(pSE3627c) Reduction in 
cell length 
Reduction in 
cell length 
Reduction in 
cell length 
    
M. tuberculosis    
H37RvS(pSE2911) Increased cell 
length 
Increased cell 
length 
No change in 
cell length 
H37RvS(pSE3330c) Increased cell 
length 
Not done* Increased cell 
length 
H37RvS(pSE3627c) Increased cell 
length 
Increased cell 
length 
Increased cell 
length 
 
Electron micrographs for the H37RvS(pSE3330) strain were characterized by large numbers of 
clumped cells. These precluded the characterization of cell length in this strain.  
The short cells observed for the heterologous M. smegmatis strains ectopically expressing Rv2911 
and Rv3627c suggest that these strains likely commit to division too early during growth, thus 
resulting in the production cells with reduced length. At this point, it is unclear if the replicated 
chromosome partitions completely in these strains. In M. tuberculosis, the increase in the 
population of cells with longer cell sizes suggests division and daughter cell separation is delayed 
when DD-CPases are over-expressed. Our study represents the first report that implicates 
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mycobacterial DD-CPases in regulating bacterial cell length and mechanisms of cell division and 
now provides exciting avenues for further study.  
4.4.6. M. tuberculosis Rv3330 and bacterial cell morphology 
Ectopic expression of Rv3330 in M. smegmatis revealed a role for this protein in governing 
bacterial cell morphology. The mc
2
(pSE3330) strain displayed a majority of cells with abnormal 
cell morphology, including bulges, division scars at the poles, chaining and kinking along the 
lateral axis of the cell. However, morphological assessment of the recombinant H37RvS strains 
ectopically expressing Rv3330 revealed none of the defects displayed by the mc
2
(pSE3330) 
strain, once again highlighting key differences between M. tuberculosis and M. smegmatis. The 
cell surface defects displayed by the heterologous M. smegmatis strain ectopically expressing 
Rv3330 are similar to those observed in E. coli, where deletion of PBP5, a direct homologue of 
MSMEG_6113, significantly affected bacterial cell shape (Nelson and Young, 2001; Ghosh et al., 
Young 2006). Genetic complementation of E. coli mutants with MSMEG_2433 reversed 
morphological defects of the mutant strain (Bansal et al., 2015), indicative of a role of 
MSMEG_2433, a direct homologue of Rv3330 in M. tuberculosis, in regulating mycobacterial 
cell morphology.  
Cell morphology in mycobacteria is dependent on multiple factors. Schoonmaker et al., (2014) 
identified a role for M. tuberculosis Ldts in regulating cell size and morphology. Deletion of Ldtm1 
and Ldtm2 from M. tuberculosis genome resulted in various effects, including reduction of 
bacterial cell size and alterations of cell morphology amongst others (Schoonmaker et al., 2014). 
DivIVA, the polar localizing protein that drives polar elongation in actinomycetes and other rod-
shaped bacteria such as B. subtilis (Halbedel et al., 2009; Letel et al., 2009) is also implicated in 
regulating bacterial cell morphology (Kang et al., 2008). Reduced expression of DivIVA in M. 
smegmatis leads to robust morphological changes such as bulging at the pole of actively growing 
cells, a defect arising from abnormal PG synthesis at the poles (Kang et al., 2008). This suggests 
that the polar defects observed for the mc
2
(pSE3330) strain (viz. kinking, division scars and 
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bulging), following ectopic expression of Rv3330, might potentially result from direct or indirect 
dysregulation of DivIVA activity by Rv3330, since the latter also localizes at both poles, as 
demonstrated in  this study. 
4.4.7. DD-CPases and the bacterial cell envelope  
Ectopic expression of M. tuberculosis DD-CPase homologues in wild type M. smegmatis caused 
significant disruptions of bacterial cell envelope architecture. The thickness of the envelope was 
increased and appeared to partially detach from the cytoplasm. However, these effects did not 
occur in M. tuberculosis. At this point, it is difficult to draw definite conclusions regarding this 
observation as the TEM data obtained for the recombinant H37RvS strains was not a 
representation of the entire population for all strains at different growth phases. These cell wall 
defects we noted in M. smegmatis were reported in M. tuberculosis following the loss of Ldtm1 and 
Ldtm2 (Schoonmaker et al., 2014), suggestive of a possible interplay between PG-hydrolase (viz. 
DD-CPases) and synthases (viz. LD-transpeptidases). 
4.5. Polar, mid-cell and quarter cell position localization of rseGFP tagged M. tuberculosis 
DD-CPase homologues  
Cellular localization studies of rseGFP tagged M. tuberculosis DD-CPase protein derivatives 
revealed a unique pattern of localization. The three proteins displayed a similar pattern of 
localization, at the poles, mid-cell and quarter cell positions. This pattern of localization suggests 
a role for M. tuberculosis DD-CPase homologues in elongation and division in mycobacteria. 
Numerous well characterized M. tuberculosis PG remodelling enzymes, are documented to be 
present at the poles of actively growing cells or the divisome of dividing cells (Kieser and Rubin, 
2014; Machowski et al., 2014). The most intriguing site of localization for the three homologues 
is at the quarter cell position, which we hypothesize serves to identify or mark future division 
sites. Another possible reason for localization at this position is to facilitate nucleoid partitioning 
during cell growth. We were unable to address this by DAPI staining of chromosomal DNA, as 
the fluorescence from the rseGFP and DAPI run through the same channel in our microscope. 
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Future studies will involve tagging the M. tuberculosis DD-CPase homologues with another 
fluorescent tag, such as mRFP, to definitively assess whether these proteins are involved in 
nucleoid occlusion or not.  
4.6. A proposed model for the function of M. tuberculosis DD-CPases 
A combination of the protein interaction data with the phenotypes displayed by the heterologous 
M. smegmatis strains, ectopically expressing the M. tuberculosis DD-CPases and localization 
analysis, allowed for the construction of a hypothetical model for the physiological role of DD-
CPase, and the sites at which they exert their effect, figure 4.1.2.  
Cell elongation
Cell morphology
Mechanisms of cell division 
Cell morphology
Colony morphology
Bacterial sliding
Biofilm formation
Growth rates
Cell wall architecture
Rv2911
Rv3330
Rv3627c
Putative interacting 
partners
 
Figure 4.1.2. A model depicting the role M. tuberculosis DD-CPase homologues. The three 
proteins localize at both poles and mid-cell, with Rv2911 and Rv3627c regulating rates of cell 
elongation at the poles and mechanisms of cell division at the septum. Rv3330 at the poles and 
septum is predominantly involved in regulating cell morphology. The quarter cell localization is 
not included mainly because it is unclear of what role these proteins play at those specific sites. 
The model predicts that these proteins exert their effect through interaction with various partners 
identified to be present at the poles or septum. 
 
  
5.1. Conclusion and future prospects 
5.1.1 Conclusion 
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Collectively, this study demonstrated the importance of mycobacterial DD-CPases in cellular 
elongation, division and maintenance of normal cell morphology. We also confirmed that 
mycobacterial DD-CPases do not function as single entities, but through interaction with various 
partners, present at the poles and septum of actively growing cells. Interrogation of the 
functionality of M. tuberculosis DD-CPase homologues by heterologous expression in M. 
smegmatis revealed that despite the observed genetic multiplicity, these proteins are not 
functionally redundant, with over-expression of Rv2911 and Rv3627c resulting in defective cell 
elongation and division while Rv3330 is involved in maintaining normal bacterial cell 
morphology. This is the first study that assigns a role for M. tuberculosis DD-CPases in 
maintaining normal bacterial colony morphology, sliding, biofilm formation and growth rates. 
Analysis of the functionality of the M. tuberculosis DD-CPase homologues in the native M. 
tuberculosis host did not yield conclusive results as observed for the heterologous M. smegmatis 
strains. Therefore, interrogation of the functionality of these proteins in M. tuberculosis, through 
gene knockout is of utmost importance since a side-by-side assessment of the physiological 
function of these homologues in a heterologous system points to important, non-redundant roles 
for DD-CPases in mycobacteria.   
5.1 Future prospects  
The heterologous M. smegmatis system revealed an important role of the M. tuberculosis DD-
CPases homologues in maintaining a variety of biological processes. Thus different approaches to 
further understand their role in M. tuberculosis will allow for detailed characterization of the 
physiological function in mycobacteria. Considering the limitations of this study, we therefore 
propose the following future studies: 
I. At this point, the transcript levels of the ectopically expressed DD-CPase homologues were 
not determined in both the heterologous M. smegmatis and the recombinant M. 
tuberculosis strains. Therefore, determining and comparing transcript levels by qPCR will 
shed light on whether these proteins are expressed at similar levels in the two organisms.  
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II. Single and combination knockout of the three DD-CPases in M. tuberculosis. It should be 
noted that Rv3627c is essential, a feature which will necessitate a knockdown approach. 
The resulting strains should be characterized for morphological and virulence defects. 
III. Further validation of putative interacting partners identified in this study using a co-
immune precipitation (pull-down) approach. Biochemical characterization of the M. 
tuberculosis DD-CPases and their interacting partners. 
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6. Appendices 
6.1 Appendix A: DNA molecular weight markers used in this study 
(A.1.1.1) Roche marker III and IV  
                                                             
 
Figure A.1.1.1. Molecular weight DNA markers.  
 
 
 
 
 
 
Roche DNA 
Marke III 
Roche DNA 
Marker IV 
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6.2. Appendix B: Gene specific primers used for PCR amplification of genes and genotypic 
confirmation of strains generated in this study.   
Table. A.1.1.1. Bacterial two hybrid primers.  
Primer pair Primer sequence Restriction site 
narB_F 
narB-R 
TCATGGCTCGCACAGACCGGATC  
CTCTCAGAGGTGTTCGTCGGCGA 
None 
MSMEG_3145_F 
MSMEG_3145_R 
CGCGCGGGATCCATGAGACGTACCGTCCGCGCT 
GCGCGCAAGCTTTCAGTATTCGATGAGCCGGGT     
BamHI 
HindIII 
MSMEG_5439_F 
MSMEG_5439_R 
CGCGCGGAATTCATGCTTCGAGGAGTTGTGGGT 
GCGCGCAAGCTTTCAGCGCGCCCCAATCCTCCC 
EcoRI 
HindIII 
MSMEG_2433_F 
MSMEG_2433_R 
CGCGCGGAATTCATGTGGAGGTACGCCTTCGGG 
GCGCGCAAGCTTTCAGAGCGCCCCGATGCTCGC 
EcoRI 
HindIII 
MSMEG_6113_F 
MSMEG_6113_R 
CGCGCGGAATTCATGAGCGATAGGCTGACGCGC   
GCGCGCAAGCTTTCATGCGCCGCATCCGCAGCT 
EcoRI 
HindIII 
 
Table A.1.1.2. Untagged M. tuberculosis DD-CPase primer sets for cloning into pSE100 and 
genotypic confirmation of generated strains.  
Primer pair Primer sequence Restriction  
site 
Rv2911_UTG_F 
Rv2911_UTG_R 
GCGCAGATCTTTAAACTCTGCGCCCATGCGA 
GCGCGCATCGATCTAGAGCGAGCCGACGCT 
BglII 
ClaI 
Rv3330_UTG_F 
Rv33330_UTG_R 
GGCCAGATCTTACTCTGCACAGACGATGGCC 
GCGCGCATCGATCTAGTGCTGCGGCCGGCGG 
BglII 
ClaI 
Rv3627c_UTG_F 
Rv3627c_UTG_R 
GCGCAGATCTAAGGCAGGAGAGCTCATGGGT 
GCGCGCATCGATTCACGTCGTGCACCCGCAGAA 
BglII 
ClaI 
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Table A.1.1.3. rseGFP and M. tuberculosis DD-CPase primer sets for 3-way cloning into pSE100 
and genotypic confirmation of generated strains.  
Primer pair  Primer sequence  Restriction  
site  
rseGFP_F 
rseGFP_R 
 
CGCGCGGAATTCATGGTGAGCAAGGGCGAGGA 
GCGCGCCTGCAGAGGAGTCCAAGCTCAGCTAA 
EcoRI 
PstI 
Rv2911_UTG_F 
Rv2911_R 
GCGCAGATCTTTAAACTCTGCGCCCATGCGA 
GGCCGAATTCGAGCGAGCCGACGCTGGCCTG 
BglII 
EcoRI 
Rv3330_UTG_F 
Rv3330_R 
GGCCAGATCTTACTCTGCACAGACGATGGCC 
GCGCGAATTCGTGCTGCGGCCGGCGGTTCAT 
BglII 
EcoRI 
Rv3627c_UTG_F 
Rv3627c_R 
 
GCGCAGATCTAAGGCAGGAGAGCTCATGGGT 
GGCCGAATTCCGTCGTGCACCCGCAGAACCA  
BglII 
EcoRI 
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6.3. Appendix C: Restriction digests 
6.3.1 Restriction profile of the mPFC backbone vectors  
6.3.1.1. Restriction profile of pUAB300 
 
       
 
pUAB300 
4913 bps 
1000 
2000 3000 
4000 
AatII 
NruI 
KpnI 
AatII 
NruI 
XhoI 
BglII 
KpnI 
BglII 
'groEL 
ORF-6 
DHFR(1,2) 
Gly6 
hygro 
'oriE 
oriM 
 
 
 
 
 
 
 
 
Figure A.1.1.2. Restriction profiling of the mPFC prey vector, pUAB300. (A) plasmid map of 
pUAB300. (B) Restriction profile of pUAB300. Lane 1= marker III, Lane 2= uncut pUAB300 
,Lane 3= XhoI, Lane 4= BglII, Lane 5= KpnI, Lane 6= NruI, Lane 7= AatII . (C) Table showing 
the expected banding profiles for pUAB300 restricted with the listed restriction enzymes. 
Restriction enzyme  Expected molecular weight  
(bps)  
XhoI  4913 
BglII  3771 
KpnI  4191  
NruI  3159 and 1754  
AatII 3786 and 1127 
A B 
C 
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6.3.1.2. Restriction profile of pUAB400 
 
 
     
 
pUAB400 
4720 bps 
1000 
2000 
3000 
4000 
NruI 
PvuI 
BglII 
XhoI 
NruI 
PvuI 
NspI 
NspI 
BglII 
oriE 
attP 
groEL 
ORF-5 
 DHFR(3)' 
kan (aph) 
int 
 
 
 
 
 
 
 
 
 
 
 
Figure A.1.1.3. Restriction profiling of the mPFC bait vector, pUAB400. (A) Plasmid map of 
pUAB400. (B) Restriction profile of pUAB400. Lane 1= marker IV, Lane 2= uncut pUAB400, 
Lane 3= XhoI, Lane 4= PvuI, Lane 5= BglII, Lane 6= NspI, Lane 7= NruI . (C) Table showing the 
expected banding profiles for pUAB300 restricted with the listed restriction enzymes. 
 
 
 
Restriction enzyme  Expected molecular weight  
(bps)  
XhoI  4720 
PvuI  4071 and 649 
BglII  3602 and 1118  
NspI  3610 and 1110  
NruI 3889 and 831 
A B 
C 
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6.4. Appendix D:  Restriction profile of pSE100 vector backbone and derivatives. 
6.4.1. Restriction profile of pSE100 vector backbone   
 
   
 
pSE100 
5538 bps 
1000 
2000 
3000 
4000 
5000 
BamHI 
PstI 
EcoRI 
EcoRI 
EcoRI 
rrnBT2 
UV15tetO 
pSE100 F 
T4g32 
pSE100 R 
ori myc 
hygR 
ColE1 
 
 
 
 
 
 
 
Figure A.1.1.4. Restriction profiling of pSE100. (A) Plasmid map of pSE100. (B) Restriction 
profile of pSE100.  Lane 1= marker IV, Lane 2= uncut pSE100,Lane 3=, PstI, Lane 4= BamHI, 
Lane 5= EcoRI, Lane 6= XhoI . (C) Table showing the expected banding profiles of pSE100 
restricted with the listed restriction enzymes. 
 
 
 
Restriction enzyme  Expected molecular weight  
(bps)  
PstI  5538  
BamHI  5538  
EcoRI  2306, 1694 and 1530  
XhoI  4688 and 850  
A B 
C 
 129 
 
 
6.4.2. Restriction profile of untagged Rv2911 cloned into pSE100 
  
 
 
 
 
 
 
 
 
Figure A.1.1.5. Restriction profiling of untagged Rv2911 cloned into pSE100 producing the 
pSE2911 construct. (A) Vector map showing untagged Rv2911 cloned into pSE100. (B) 
Restriction profile pSE2911 construct. Lane 1= Marker IV, Lane 2= Uncut pSE100, Lane 3= 
SphI, Lane 4= EcoRI, Lane 5= PvuI, Lane 6= XhoI. (C) Table showing the expected banding 
profiles of pSE2911 construct restricted with the listed restriction enzymes.  
 
 
 
Restriction enzyme  Expected molecular weight  
(bps)  
SphI  6361  
EcoRI  4055 and 2306  
PvuII  5316 and 1225  
XhoI  5511 and 850  
 
Rv2911_UTG+pSE100 
6361 bps 
1000 
2000 
3000 
4000 
5000 
6000 
PvuII 
PvuII 
XhoI 
XhoI 
EcoRI 
EcoRI 
SphI 
PvuII 
'Rv2911_UTG 
pSE100 R 
ori myc 
hygR 
ColE1 
rrnBT2 UV15tetO 
pSE100 F 
A B 
C 
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6.4.3. Restriction profile of untagged Rv3330 cloned into pSE100  
 
 
Rv3330_UTG+pSE100 
6703 bps 
1000 
2000 
3000 
4000 
5000 
6000 
BamHI 
SphI 
NruI 
XhoI 
XhoI 
EcoRI 
EcoRI 
NruI 
SphI 
'Rv3330_UTG 
pSE100 R 
ori myc 
hygR 
ColE1 
rrnBT2 UV15tetO 
pSE100 F 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A.1.1.6. Restriction profiling of untagged Rv3330 cloned into pSE100 to generate the 
pSE3330 construct. (A) Vector map showing untagged Rv3330 cloned into pSE100. (B) 
Restriction profiling of pSE3330 construct. Lane 1= Marker IV, Lane 2=  uncut pSE100, Lane , 
Lane 3= BamHI, Lane 4= EcoRI, Lane 5= NruI, Lane 6= XhoI, Lane 7= SphI. (C) Table showing 
the expected banding profiles of pSE3330 construct restricted with the listed restriction enzymes  
 
 
 
Restriction enzyme  Expected molecular weight  
(bps)  
BamHI  6703  
EcoRI  4397 and 2306  
NruI  4393 and 2310  
XhoI  4393 and 2310  
SphI  6081 and 622  
A 
B 
C 
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6.4.4. Restriction profile of untagged Rv3627c cloned into pSE100  
 
      
 
Rv3627C_UTG + pSE100 
6871 bps 
1000 
2000 
3000 4000 
5000 
6000 
XbaI 
PvuII 
PvuII 
SalI 
ClaI 
SalI 
SalI 
BglII 
EcoRI 
SalI 
EcoRI 
rrnBT2 
UV15tetO 
pSE100 F 
'Rv3627c_UTG 
pSE100 R 
ori myc 
hygR 
ColE1 
 
 
 
 
 
 
 
 
 
Figure A.1.1.7. Restriction profiling of untagged  Rv3627c cloned into pSE100 to generate the 
pSE3627c construct. (A) Vector map showing untagged Rv3627c cloned into pSE100. (B) 
Restriction profiling of pSE3627c construct. Lane I= Marker III, Lane 2= uncut pSE100, Lane 3= 
SphI, Lane 4= XhoI, Lane 5=PvuII, Lane 6= NotI, Lane 7= EcoRI. (C) Table showing the 
expected banding profiles of pSE3627c construct restricted with the listed restriction enzymes. 
 
 
 
Restriction enzyme  Expected molecular weight  
(bps)  
SphI  6871 
XhoI  6021 and 850  
PvuII  6009 and 862  
NotI 3093, 2474 and 1037 
EcoRI  4565 and 2306  
A B 
C 
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6.5. Appendix E: Restriction profiling of rseGFP tagged M. tuberculosis DD-CPase 
derivatives into pSE100  
6.5.1. Restriction profiling of C-terminally rseGFP tagged Rv2911  cloned into pSE100 
 
     
 
Rv2911 + rsEGFP + pSE100 
7060 bps 
1000 
2000 
3000 4000 
5000 
6000 
7000 
XbaI 
PvuI 
EcoRI 
XhoI 
XhoI 
PvuI 
EcoRI 
EcoRI 
rrnBT2 
UV15tetO 
pSE100 F 
'Rv2911' 
'rsEGFP' 
pSE100 R 
ori myc 
hygR 
ColE1 
 
 
 
 
 
 
 
Figure A.1.1.8. Restriction profiling of rseGFP C-terminally tagged Rv2911 cloned into pSE100 
to generate the pSE2911-rseGFP construct. (A) Vector map showing rseGFP C-terminally tagged 
Rv2911. (B) Restriction profiling of pSE2911-rseGFP construct. Lane I= Marker IV, Lane 
2=uncut pSE100, Lane 3= XbaI, Lane 4= XhoI, Lane 5=PvuI, Lane 6= EcoRI. (C) Table showing 
the expected banding profiles of pSE2911-rseGFP construct with the listed restriction enzymes.  
 
6.5.2. Restriction profiling of C-terminally rseGFP tagged Rv3330 cloned into pSE100.  
Restriction enzyme  Expected molecular weight  
(bps)  
XbaI  7174 
XhoI  6324 and 850  
PvuI  4632 and 2542  
EcoRI 2570, 2306, 1538 and 760 
A B 
C 
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Rv3330-rsEGFP+pSE100 
7516 bps 
1000 
2000 
3000 
4000 
5000 
6000 
7000 
XbaI 
EcoRI 
PstI 
EcoRI 
StyI 
StyI 
XmnI EcoRI 
StyI 
XmnI 
EcoRI 
rrnBT2 
UV15tetO 
pSE100 F 
'Rv3330' 
'rsEGFP 
T4g32 pSE100 R 
ori myc 
hygR 
ColE1 1
21226
2912
bps
5148
4268
2027
1584
1375
947
831
2 3 4 5 6 7
7516 7516
760
2306
6059
1538
1457
5306
1401
809
bps
 
 
 
 
 
 
 
 
Figure A.1.1.9. Restriction profiling of rseGFP C-terminally tagged Rv3330 cloned into pSE100 
to generate the pSE3330-rseGFP construct. (A) Vector map showing rseGFP C-terminally tagged 
Rv3330. (B) Restriction profiling of pSE3330-rseGFP construct. Lane I= Marker III, Lane 2= 
uncut pSE100, Lane 3= XbaI, Lane 4= PstI, Lane 5= StyI, Lane 6= XmnI, Lane 7= EcoRI. (C) 
Table showing the expected banding profiles of pSE3330-rseGFP construct with the listed 
restriction enzymes. 
 
 
 
 
 
Restriction enzyme  Expected molecular weight  
(bps)  
XbaI  7516 
PstI  7516  
styI  5306, 1401 and 809  
XmnI 6059 and 1457 
EcoRI 2921, 2306, 1538 and 760 
A B 
C 
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6.5.3. Restriction profiling of C-terminally rseGFP tagged Rv3627c cloned into pSE100.  
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Figure A.1.1.10. Restriction profiling of rseGFP C-terminally tagged Rv3627c cloned into 
pSE100 to generate the pSE3627c-rseGFP construct. (A) Vector map showing rseGFP C-
terminally tagged Rv3627c. (B) Restriction profiling of pSE3627c-rseGFP construct. Lane 1= 
Marker IV, Lane 2= uncut pSE100, Lane 3= BamHI, Lane 4= XhoI, Lane 5=NruI. (C) Table 
showing the expected banding profiles for pSE3627c-rseGFP construct with the listed restriction 
enzymes 
 
 
 
 
Restriction enzyme  Expected molecular weight  
(bps)  
BamHI  7684 
XhoI  6839 and 850 
NruI  5193 and 2491  
A B 
C 
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6.6. Appendix F: Culture media: 
6.6.1. E. coli culture media  
LB    10 g tryptone, 10 NaCl, 5 g yeast extract in 1 L dH2O 
2xTY    20 g tryptone, 10 g NaCl, 10 g yeast extract in 1 L dH2O 
LA    10 g tryptone, 5 NaCl, 5 gyeast extract, 15 g agar in 1 L dH2O 
  
6.6.2. M. smegamtis culture media 
Middlbrook 7H9 4.7 g Middlebrook 7H9, 10 ml of 100x glucose salts, 2 ml glycerol, 
, 2 ml 25% Tweeen80 in 1 L dH2O 
 
Middlebrook 7H10 19 g Middlebrook 7H10, 10 ml of 100x glucose salts, 5 ml glycerol 
in 1 l dH2O 
 
100x glucose salts 20 g glucose, 8.5 g NaCl dissolved in 100 ml dH2O 
 
6.6.2. M. tuberculosis culture media 
Middlebrook 7H9 4.7 g Middlebrook 7H9, 10o ml OADC, 2 ml glycerol, , 2 ml 25% 
Tweeen80 in 1 L dH2O 
 
Middlebrook 7H11 19 g Middlebrook 7H10, 10o ml OADC, 5 ml glycerol in 1 l dH2O 
 
 
6.7. Appendix G: Specialised media 
6.7.2.  Minimal Souton’s media 4 g asparagine, 0.5 MgSO4, 2 g citric acid, 0.5 g 
KH2PO4, 0.005 g ammonium ferric acids, 
60 ml glycerol is 1 L dH2O. Adjust pH to 7.3.  
 
6.7.3.  Molility semi-solid media 4.7 g Middlebrook 7H9, 2 ml glycerol, agar or 
agrose to a final concwentration of 0.3% and  
allow to dry overnight at room temperture 
 
6.8. Appendix H: DNA extraction solutions  
6.8.1.  Plasmid DNA extraction for E. coli solutions  
Solution I 50 mM glucose, 25 mM Tris-HCl (pH 8), 10 mM   
EDTA in dH2O 
Solution II 1% SDS, 0.2 M NaOH dissolved in sdH2O 
Solution III 3 M potassium acetate, 11.5% acetic acid dissolved 
in sdH2O  
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6.8.2. Genomic DNA extraction solutions for mycobacteria 
CTAB 4.1 % NaCl, 10% N-cetyl-N,N, N-trimethyl 
ammonium bromide dissolved in dH2O  
TE Buffer  10 mM Tris-HCl (pH 8), 10 mM EDTA dissolved in 
dH2O  
 
Chloroform: Isoamyl alcohol              24 ml chloroform, 1 ml isoamyl alcohol 
Phenol:chloroform   1 ml phenol, 1 ml chloroform 
Sodium acetate   3M sodium acetate dissolved in dH2O, pH 5.2  
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